Synthesis and Characterization of Double Network Hydrogels Containing Norbornene-Modified Carboxymethyl Cellulose and Cellulose Nanofibrils by Morrison, Tessali Xiaozhu
The University of Maine 
DigitalCommons@UMaine 
Electronic Theses and Dissertations Fogler Library 
Summer 8-22-2020 
Synthesis and Characterization of Double Network Hydrogels 
Containing Norbornene-Modified Carboxymethyl Cellulose and 
Cellulose Nanofibrils 
Tessali Xiaozhu Morrison 
University of Maine, tessali.morrison@maine.edu 
Follow this and additional works at: https://digitalcommons.library.umaine.edu/etd 
Recommended Citation 
Morrison, Tessali Xiaozhu, "Synthesis and Characterization of Double Network Hydrogels Containing 
Norbornene-Modified Carboxymethyl Cellulose and Cellulose Nanofibrils" (2020). Electronic Theses and 
Dissertations. 3313. 
https://digitalcommons.library.umaine.edu/etd/3313 
This Open-Access Thesis is brought to you for free and open access by DigitalCommons@UMaine. It has been 
accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of 
DigitalCommons@UMaine. For more information, please contact um.library.technical.services@maine.edu. 
SYNTHESIS AND CHARACTERIZATION OF DOUBLE NETWORK 
 
HYDROGELS CONTAINING NORBORNENE-MODIFIED 
 
CARBOXYMETHYL CELLULOSE AND 
 
CELLULOSE NANOFIBRILS 
 
By 
 
Tessali Xiaozhu Morrison 
 
B.S. University of Maine, 2018 
 
 
A Thesis 
 
Submitted in Partial Fulfillment of the 
 
Requirements for the Degree of 
 
Master of Science 
 
(in Chemistry) 
 
 
The Graduate School 
 
The University of Maine 
 
August 2020 
 
 
Advisory Committee: 
 
William Gramlich, Associate Professor of Chemistry, Advisor 
 
Alice Bruce, Professor of Chemistry 
 
Michael Kienzler, Assistant Professor of Chemistry 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright 2020 Tessali Morrison 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SYNTHESIS AND CHARACTERIZATION OF DOUBLE NETWORK 
HYDROGELS CONTAINING NORBORNENE-MODIFIED 
CARBOXYMETHYL CELLULOSE AND 
CELLULOSE NANOFIBRILS 
 
By Tessali Morrison 
 
Thesis Advisor: Dr. William M. Gramlich 
 
An Abstract of the Thesis Presented 
in Partial Fulfillment of the Requirements for the 
Degree of Master of Science 
(in Chemistry) 
 
August 2020 
 
 
Double network hydrogels were synthesized using two cellulose derivatives, 
carboxymethyl cellulose (CMC) and cellulose nanofibrils (CNF). CMC was functionalized to 
incorporate norbornene groups via amide linkages onto its backbone. These norbornene groups 
were later crosslinked using dithiol crosslinkers during hydrogel synthesis. CNF was also 
incorporated into these hydrogels via physical entrapment within the networks. In the final steps, 
UV radical initiators and irradiation were also used to form hydrogels. 
To better understand the structures and functions of these hydrogels, key properties such 
as swelling, moduli, and degradation were explored. Through this research, it was discovered that 
a critical number of effective crosslinks was required to form hydrogels. This revealed that certain 
hydrogel formulations were not viable. The addition of CNF produced hydrogels containing higher 
moduli and slower degradation rates. As the percentage of CNF varied, so did its function within 
the double networks. At lower percentages, CNF played a reinforcing role, while at higher 
 
percentages, interpenetrating networks (IPNs) were created. Ultimately, a high degree of control 
over hydrogel moduli and CNF composition was achieved. 
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CHAPTER 1 
Chapter 1. Introduction 
INTRODUCTION 
 
1.1 Hydrogels 
 
Hydrogels are three-dimensional polymeric networks held together using junctions known 
as crosslinks. These networks are made using hydrophilic polymers and can be visualized as nets; 
they consist of long polymer chains tethered together via crosslinks (Figure 1.1) and allow the flow 
of certain materials in and out. 
 
Figure 1.1 – Hydrogel Network: A schematic representation of a hydrogel network consisting of 
polymer chains tethered together via crosslinks. 
 
Initially, hydrogels exist as liquid solutions, and, upon gelation through a variety of 
possible techniques, effectively gel to form solid products (Figure 1.2). The ability to instigate 
gelation using numerous techniques also adds to the versatility of these hydrogels. Initiation 
methods may be selected based on compatibility with the hydrogel’s application, thus expanding 
potential hydrogel applications. Even further, the different initiation methods themselves can be 
used to incorporate varying crosslinkers that may not otherwise tolerate other initiation methods. 
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Figure 1.2 – Hydrogel Gelation Process: A schematic representation of the gelation process using 
UV light. 
 
Once formed, the hydrogels have the ability to swell significant percentages of their 
original size, while still retaining their network structure. This is especially useful for a multitude 
of applications, such as water or solvent release. Another key characteristic of hydrogels is the 
variability of their composition. When it comes to composition, hydrogels have substantial options 
for applicable polymeric materials and crosslinkers. More specifically, because hydrogels are 
synthesized using polymers, and there exists an immense number of polymers, hydrogels can be 
created using a colossal library of polymers. Similarly, because numerous reactions can be used to 
form crosslinks, a sizeable number of potential crosslinkers also exist. Even further, because not 
all crosslinks employ the same mechanism for holding hydrogels together, choosing the types of 
crosslinks also allows for hydrogel tunability. Furthermore, because hydrogel composition can 
vary widely, materials can be specifically selected to yield particular properties and produce 
desired outcomes from these hydrogels. As a result of the vast applicable materials, the moduli 
and degradation rates of hydrogels can be fine-tuned. 
 
 
 
 
3 
1.2 Hydrogel Applications 
 
1.2.1 Agriculture 
 
Hydrogels have been shown to be very useful in agricultural applications because of their 
ability to both absorb and release large amounts of water. Consequently, scientists developing 
ways to grow plants in areas where the soil is lacking moisture have used hydrogels to deliver 
water to plants over time.1 The hydrogels were originally swollen with water, and then 
incorporated into the soil. Over time, the hydrogels would then release water into the soil, 
essentially watering plants that otherwise would not receive the required water (Figure 1.3). This 
method has been shown to be an effective way to grow and maintain plants that otherwise would 
have died due to lack of water in their original conditions. 
 
Figure 1.3 – Water Release via Hydrogels Immersed in Soil: A schematic showing the release of 
water from hydrogels that had been previously incorporated into soil. 
 
Development of hydrogels made specifically for agricultural applications requires 
hydrogels to contain components that prefer swelling and subsequent solvent release. Some of 
these factors include the incorporation of hydrophilic groups and lower crosslink density within 
hydrogel networks.2 More recent studies have found utilizing polysaccharide-based hydrogels to 
be advantageous because they are renewable, biodegradable, and nontoxic.3 As a result, 
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polysaccharide-based hydrogels have become a focus for many agricultural applications. In 
addition to providing moisture in the form of water to plants, hydrogels have also been swollen 
with things such as urea, to provide nitrogen to the soil.4 While the common idea has been to use 
hydrogels to deliver water to soil, hydrogels have also demonstrated their ability to deliver other 
nutrients to soils, thus expanding their potential applications within agriculture. Similarly, in order 
to deliver various nutrients to plants, an assortment of monomers has been explored. The use of a 
phosphate monomer (2-(methacryloyloxy)ethyl phosphate) to synthesize hydrogels for soil 
immersion showed the release of phosphate into the soil, resulting in a new method to add 
phosphorus to phosphorus-lacking soils.5 
 
1.2.2 Anti-biofouling 
 
As a result of the growing aquaculture field and increased awareness of sustainability and 
conservation, anti-biofouling has become a focus for scientists around the world. Hydrogels have 
been utilized as anti-biofouling agents, coating submerged surfaces such as boats, nets, and docks,6 
because of their abilities to prevent microorganism buildup without harming their surrounding 
environments. Over time, submerged surfaces can collect coatings of microorganisms found in the 
surrounding areas (Figure 1.4). These microorganism buildups are undesirable because they 
contribute to decreased efficiency and shorter lifetimes of various marine equipment.7 In addition 
to improving equipment quality, these coatings are environmentally friendly, as they do not contain 
toxic components such as lead, arsenic, and tar.8 More recent attempts to combat biofouling 
included the use of copper,9 but resulted with similar environmental damage to the organisms in 
the surrounding areas.10 
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Figure 1.4 – Biofouling Prevention via Hydrogel Coatings: A schematic showing the use of a 
hydrogel coating on an anchor preventing rust and microorganism buildup. 
 
As hydrogels became more widely used as anti-biofouling agents, ideas to expand their 
applications into becoming antibacterial agents arose. In some situations, hydrogel systems 
containing cationic components were explored because of their ability to disrupt bacterial cell 
membranes, essentially acting as antibacterial agents.11 Some more complex approaches in anti-
biofouling applications include the incorporation of multiple components into hydrogel networks 
to create specific areas of antibacterial functionality.12 On other fronts, hydrogel coatings have 
been used to prevent bacterial buildup on medical devices such as catheters.13 While studies have 
showed that poly(ethylene glycol) (PEG) is the most common polymer used for anti-biofouling 
applications, a multitude of other polymers have also been explored.14 
 
1.2.3 Pharmaceuticals and Controlled Drug Delivery 
 
Due to their unique ability to swell and release water, hydrogels have found their way into 
a multitude of pharmaceutical and controlled drug delivery applications. Similar to how they 
function as water and nutrient providing tools within agricultural applications, hydrogels can also 
release other materials, such as proteins15,16 or other small molecules,17,18 through similar processes 
(Figure 1.5). Unlike the agricultural applications, many of these hydrogels exhibit controlled 
release triggered by enzymes.19 These hydrogels contain sections that can undergo enzymatic 
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cleavage, and upon introduction into the system, the networks are degraded by the surrounding 
enzymes, effectively causing the release of the contained materials.20 Further research within this 
area has shown that hydrogels can be fine-tuned to respond to specific enzymes, thus increasing 
the selectivity achieved using these drug release systems.21 
 
 
Figure 1.5 – Controlled Drug Delivery via Hydrogels: A schematic showing the release of small 
molecules and their potential effects, such as cell proliferation (left) or differentiation (right), on 
cells in the surrounding areas. 
 
In addition to their swelling and release properties, hydrogels also make excellent materials 
for controlled drug delivery because of their tunable mechanical strength, biocompatibility, and 
degradation.22 Because their moduli can be controlled, hydrogels can be synthesized to mimic 
various tissue types, effectively acting as internal scaffolds in addition to controlled drug delivery 
agents.23 Following the idea of functioning as biological scaffolds, hydrogel structures are desired 
to be malleable enough to match the gaps that they may fill when performing these functions 
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(Figure 1.6). Additionally, hydrogels that are to be introduced into biological systems carry the 
requirement of integrating themselves into these systems without causing an immunoresponse or 
leaving residual materials once they have completed their roles.24 While degradation is known to 
play a role in the release of materials over time, many questions still remain surrounding this 
tunable hydrogel property. Controlling hydrogel degradation can monitor the release rates of 
materials and adjust them based on the external environment. For example, in a specific scenario 
where hydrogels are responsible for releasing growth hormones at a wound site, a specific rate of 
hydrogel degradation could be employed to control the amounts of growth hormone released and 
match rate of healing.25 
 
 
Figure 1.6 – A Hydrogel Used as a Tissue Scaffold: A schematic representation of a divot caused 
by some external damage that if left alone may become occupied with other materials such as 
other tissues (represented in green), causing discomfort (left), or filled using a hydrogel scaffold 
for support (right). 
 
It follows that, as the pharmaceutical and controlled drug delivery applications of hydrogels 
have increased, hydrogel syntheses have also evolved. Firstly, the known initiation methods 
expanded to include some of the more popular techniques such as photopolymerizations or redox 
reactions.26 Hydrogels with physical crosslinks breakdown as the chains become less entangled, 
8 
while chemically crosslinked hydrogels require external forces such as enzymes or hydrolysis for 
such breakdown.27 In terms of controlled release, hydrogels employing each type of crosslink have 
their advantages and disadvantages, but generally hold the molecules intended for release and 
deliver them via diffusion. However, chemical modifications can also be made to attach 
components to the polymer surfaces.28 Initially, when considering physically crosslinked 
hydrogels, the concern was that they would dissipate too quickly in solution, thus preventing 
controlled drug release over time. On the other hand, chemically crosslinked hydrogels would 
remain intact under harsher conditions, but often required the use of many cytotoxic crosslinkers. 
Studies monitoring the drug release associated with each type of crosslink showed that physically 
crosslinked hydrogels can in fact compete with chemically crosslinked ones.29 As a result, many 
hydrogels used in biological systems contain physical crosslinks. 
Hydrogels used in pharmaceutical or controlled drug delivery applications have been 
synthesized using a wide variety of materials. From commercial polymers such as poly(vinyl 
alcohol)30 or branched poly(ethylene glycol),31 to sustainable polymers such as chitosan32 or 
alginate.33 As a result, these hydrogels can be utilized for controlled drug delivery in areas of the 
body such as the nose,34 eye,35 or colon.36 In more complex applications, the materials delivered 
by these hydrogels can be used for a variety of purposes, such as promoting angiogenesis37 or 
cartilage regeneration.38 
 
1.2.4 Tissue Scaffolds and Three-Dimensional Cell Culture 
 
As medicine and technology have advanced, so have the ideas surrounding tissue 
regeneration and cell culture. New techniques to regenerate tissues found all over the body have 
been explored, with the hopes of developing and optimizing procedures designed to aid growth 
and proliferation of various cell types. Due to their tunable properties and multitude of design 
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possibilities, hydrogels have received attention as potential scaffolds for tissue regeneration and 
three-dimensional cell culture structures. 
Hydrogels can be used as cell scaffolds in applications where they fill biological gaps by 
mimicking various tissues in the body (Figure 1.6). However, the use of hydrogels as scaffolds 
goes one step further with cell encapsulation within these scaffolds (Figure 1.7). Incorporating cell 
encapsulation into the hydrogels can allow for wound healing and tissue regeneration at the target 
sites. Additionally, these applications showcase hydrogels functioning as two types of support 
systems; the first being the hydrogel filling the space where tissue and support are lacking, and the 
second being a three-dimensional matrix to grow and regenerate cells. One of the most 
advantageous aspects of using hydrogels that function as both tissue and cell scaffolds is that the 
introduction of foreign materials within the body is limited. Instead of requiring two separate 
components, one to support the tissues during the healing process and one to promote cell growth 
and proliferation, hydrogels complete these tasks as one unit. Minimizing the number of 
components required for invasive biomedical applications is preferred to reduce the potential for 
the body’s immunoresponse, cost, and procedures required to implement such technologies. 
 
Figure 1.7 – Use of Hydrogels Containing Cells as Tissue Scaffolds: A schematic representation 
of hydrogels used as tissue scaffolds either without (left) or with (right) cells incorporated into 
them. 
 
While inside the hydrogel matrices, cells can grow, proliferate, and differentiate. When 
encapsulated in the hydrogels, cells cannot naturally adhere to surfaces, so without additional 
assistance they remain spherical and locked in place within the networks (Figure 1.8). Cell viability 
and growth within hydrogels have been shown to be successful due to the introduction of materials 
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such as various growth hormones, proteins and amino acids, or signaling and binding molecules. 
With the addition of various other components into the hydrogel matrices, cells trapped within 
hydrogels have exhibited growth, proliferation, and differentiation, as well as cellular migration39 
and adhesion.40 More specifically, while adhesion is not natural for cells within hydrogel matrices, 
it can be promoted with things such as arginylglycylaspartic acid (RGD) peptides.41 
 
Figure 1.8 – 2D vs 3D Cell Culturing Techniques: A schematic representation showing how cells 
grown in petri dishes (top) adhere to the surfaces, while those grown in hydrogels (bottom) may 
undergo changes, such as differentiation, but ultimately remain in place. 
 
Due to their three-dimensional network structures making diffusion in and out possible, 
hydrogels can play appreciable roles as cell scaffolds. The tunable moduli, swelling, and 
degradation properties of hydrogels allow them to be custom tailored to ensure the most success 
when it comes to cell growth and development. Over time, different methods to keep cells within 
hydrogel networks have surfaced and subsequently evolved. While some scenarios take advantage 
of the polymer chains with the hydrogel networks and use them to encapsulate cells, the addition 
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of various proteins and binding sites into the hydrogel matrices provides other methods for 
tethering the cells (Figure 1.9). The addition of these external factors such as signaling molecules 
and binding sites allows for control and regulation of cell activity with the hydrogel networks.42 
 
Figure 1.9 – Cell Encapsulation within Hydrogel Networks: A schematic representation of cells 
held within a hydrogel matrix via entanglement within polymer chains (left) or using binding 
sites and proteins (right). 
 
Because hydrogel networks allow diffusion, cells entrapped within hydrogels can receive 
necessities, such as nutrients and oxygen, while remaining in place within the hydrogels. Three-
dimensional cell culture is more realistic to how cells would naturally grow and develop within 
biological systems. Another advantage of using three-dimensional cell culturing techniques is the 
general immobility of the cells within these hydrogels. Isolation of cells can be especially helpful 
for studying their behavior, growing and expanding cell lines, and observing differentiation. 
Hydrogels have also been synthesized using various extracellular matrix proteins such as 
collagen,43 elastin,44 or fibrin,45 as well as other materials such as adipose tissue.46 Hydrogels 
composed using combinations of various extracellular matrix materials have also been developed, 
as they can provide multiple advantages associated with each type of material.47 These types of 
hydrogels are advantageous because they can accommodate the introduction of various cell types 
seamlessly while providing the required maintenance and support. As a result of their ability to 
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grow and sustain an assortment of different cell types, hydrogels have been utilized in a variety of 
cell growth and regeneration applications ranging from growing adipose tissue48 to cartilage49 to 
bone cells.50 Additionally, cells have been isolated and grown separately within hydrogels in 
applications such as skin51 and stem cell transplants.52 
 
1.3 Cellulose Derivatives 
 
Carboxymethyl cellulose (CMC) (Figure 1.10) is a water-soluble, cellulose-based polymer 
used in a variety of applications. Initially, the carboxymethyl groups are added to cellulose via 
Williamson ether synthesis.53 Once attached, the carboxymethyl groups improve the solubility of 
CMC,54 making it desirable for aqueous reactions and applications. CMC has been used as an 
additive,55 suspension agent,56 support,57 and absorbent.58 In addition to cellulose, 
carboxymethylation can be performed on a variety of polysaccharides, such as starch,59 chitin,60 
and dextran.61 Due to the reactivity provided by the carboxymethyl groups (Figure 1.10), the free 
hydroxyl groups of CMC have been used for further chemical modifications such as 
esterification62,63 or amidation.64,65 CMC based hydrogels have been crosslinked using a variety of 
crosslinkers, such as polyethylene glycol66 and aluminum sulfate,67 and have demonstrated 
immense water uptake ability.68 As a result of their tunability and desirable properties, CMC 
hydrogels have been used to remove pollutants from water69 or as injectable soft tissue filler.70 
 
Figure 1.10 – Chemical Structure of CMC: The chemical structure of carboxymethyl cellulose. 
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Cellulose nanofibrils (CNF) are a type of branching cellulose fibers (Figure 1.11) with 
diameters ranging from 5 to 50 nm, and lengths around 3 to 4 µm. CNF comes from plant cell 
walls and can be produced using a variety of methods. These methods span from employing 
chemicals, such as during the TEMPO-mediated oxidation,71 to completely physical processes, 
such as mechanical fibrillation72 with blenders.73 With compression moduli ranging from 12-18 
GPa,74 CNF has been used as material for coatings,75 laminates,76 and aerogels.77 As a result of its 
mechanical strength and fibrillation, CNF has been used as reinforcing agents within hydrogels 
made using softer materials, such as collagen.78 CNF has also been used as the main component 
of hydrogels,79 with these hydrogels showing cytocompatibility80 and the ability to mimic the 
moduli of various tissues such as liver.81 
 
Figure 1.11 – Schematic of CNF: A schematic showing the branching fibers of CNF. 
 
1.4 Types of Crosslinks 
 
As the junctions tethering the hydrogel networks together through various means, 
crosslinks play a crucial role in the synthesis, characterization, structure, and function of hydrogels. 
One of the most common challenges that a hydrogel’s network and structure faces is remaining 
intact and functional when swollen. More specifically, when swollen, crosslinks offer hydrogels 
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the ability to tether their networks together and resist damage. Hydrogels created with an 
insufficient number of crosslinks, or none (Figure 1.12), may experience breaks of varying 
magnitudes, which could lead to disintegration of various extents. Along the same lines as the 
resistance to swelling, crosslinks aid the hydrogels when it comes to network degradation. 
 
Figure 1.12 – Dissipation of a Hydrogel Network Lacking Crosslinks: A schematic 
representation illustrating how a group initial polymer chains congregated together without 
crosslinks dissipate upon the addition of solvent. 
 
  To add to the complexity and variety of crosslinks, there exist two classifications: chemical 
and physical. However, regardless of whether they are categorized as chemical or physical, 
crosslinks must be strong enough to resist potential damage caused by swelling or applied forces, 
while also being durable enough to withstand network degradation over time. While the general 
contributions to the hydrogel networks are essentially the same in both chemical and physical 
crosslinks, their syntheses are altogether independent. As a result of these differences, each method 
has its advantages and disadvantages, leading to preferences for certain processes over others. The 
option to employ either chemical, physical or a combination of the two types of crosslinks has 
expanded the current hydrogel applications and continues to do so. 
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1.4.1 Chemical Crosslinks 
 
Chemical crosslinking requires chemical reactions to occur, thus forming chemical bonds 
that secure hydrogel networks together. Seeing as chemical bonds are created during these 
processes, chemical crosslinks are more permanent than physical. Chemical crosslinks work to 
compensate for any stress applied to the hydrogel systems from swelling (Figure 1.13) or other 
external forces. These crosslinks also aid in the prevention of network degradation, as many of 
them are created to be stable over long periods of time. One of the drawbacks associated with this 
type of crosslink is that after any network damage these crosslinks cannot regenerate themselves. 
 
Figure 1.13 – Network Swelling of a Chemically Crosslinked System: A schematic 
representation of a chemically crosslinked network expanding but remaining intact upon 
swelling. 
 
As a result of the extremely general definition of chemical crosslinks, a multitude of 
chemical reactions can be used as tools to create these junctions. More specifically, a variety of 
functional groups can be used to create chemical crosslinks using separate reaction types. As one 
of the more reactive functional groups, aldehydes have been utilized as crosslinkers. Particular 
studies focusing on aldehyde crosslinkers have utilized glutaraldehyde to crosslink vinyl polymers 
such as poly(vinyl alcohol)82 and proteins via peptides.83 When the results of these studies revealed 
16 
the cytotoxicity of glutaraldehyde, other routes were explored, one of which discovered the use of 
dextran dialdehyde as a cytocompatible crosslinker.84 Similar to taking advantage of reactive 
functional groups, macromolecules, such as enzymes,85 have also been implemented into roles as 
chemical crosslinkers. Specific examples of these include the crosslinking of hydrogels using 
transglutaminase86 and proteins using tyrosinase.87 
In addition to using specific functional groups or macromolecules as crosslinkers, an 
assortment of reaction classes has also been exercised. The first of which being crosslinking via 
addition reactions. Specifically, addition reactions have been used in tandem with divinylsulfone88 
and 1,6-hexanedibromide89 crosslinkers. Other addition reactions have employed irradiation to 
generate chemical crosslinks within systems containing polymers such as poly(ethylene oxide)90 
and poly(vinyl alcohol).91 Another class of reactions includes condensation reactions, most 
commonly used to create amide linkages.92, 93 
 
1.4.2 Physical Crosslinks 
 
Physical crosslinks, like chemical crosslinks, are also responsible for the same network 
functions. Unlike chemical crosslinks, physical crosslinks are not created via covalent bonds, nor 
are they held together via chemical bonds. Instead, physical crosslinks utilize the existing 
properties of the polymers and their tendencies to create crosslinks on their own. Perhaps the most 
rudimentary example of the creation of physical crosslinks is due to entanglement. Networks 
created via entanglement do not rely on the same types of chemical interactions. More specifically, 
in these situations, polymer chains become entangled and intertwined forming a network. The 
chains become so interweaved that they do not separate when they are swollen or under applied 
forces. Additionally, this entanglement prevents the degradation of these hydrogels. 
17 
The prominence of physical crosslinks can be largely attributed to their ability to self-
heal.94 Because these crosslinks are not formed using chemical bonds, if they experience damage, 
such as breaks, they can regenerate themselves (Figure 1.14). For this reason, hydrogels containing 
physical crosslinks have been studied for their self-healing abilities in various applications. On the 
other hand, a setback of choosing physical crosslinks is that they are formed via dynamic 
interactions. Despite a hydrogel’s ability to reestablish physical crosslinks, its means of 
maintaining these crosslinks may not be ideal for certain applications. If a hydrogel with more 
constant and reliable crosslinks is desired, physical crosslinks may not be the best choice. 
 
 
Figure 1.14 – Network Regeneration of a Physically Crosslinked System: A schematic 
illustration of a physically crosslinked network which, upon swelling, loses a piece, but is then 
able to reincorporate the missing piece back into the network. 
 
Because the formation of physical crosslinks does not require separate crosslinkers to be 
added to the system, hydrogels made using these crosslinks are often cytocompatible.95 Many 
crosslinkers employed during chemical crosslinking reactions are cytotoxic, and thus limit the 
potential applications of the resulting hydrogels. The simplicity and limited reagent requirements 
make hydrogels with physical crosslinks particularly attractive for biomedical applications. 
Specifically, multiple studies have utilized alginate as a polymeric material used to create 
hydrogels that could then encapsulate cells and function as 3D cell culture matrices.96, 97, 98 These 
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hydrogels were particularly successful because their synthesis did not require the use of potentially 
cytotoxic crosslinkers. 
One of the most prominent techniques used to create physical crosslinks takes advantage 
of ionic interactions within the systems. Many polymers can be used in these processes, such as 
the renewable chitosan99 and dextran.100 The synthesis of physical crosslinks plays to the 
advantages of a material’s inherent properties. More specifically, crystallization has been used as 
a method to create physical crosslinks. Whether it be by self-assembly of block and graft 
copolymers101 or the emergence of crystallites,102 crystallization has been used to form physical 
crosslinks. 
As the strongest intermolecular force, the hydrogen bond can play a significant and 
powerful role in the formation of physical crosslinks. Polymers showcasing areas of functionality 
susceptible to hydrogen bonding can be prone to developing hydrogen bonds which can then lead 
to physical crosslinks. Polymers that are good candidates for creating these types of bonds take 
advantage of things such as hybridization103 and surface area.104 
 
 
1.5 Thiol-ene Reactions 
 
Thiol-ene reactions are a class of reactions used to create new carbon-sulfur bonds, and 
when employed in hydrogel syntheses, generate chemical crosslinks. In order to create new 
carbon-sulfur bonds, these reactions require terminal or “free” thiols and alkenes to be available 
and present. One of the advantages of utilizing a thiol-ene reaction is that a variety of initiators are 
available for use in these reactions. Prior to the thiol-ene initiation, the initiator must be fragmented 
to generate a minimum of one free radical. These radicals can be formed via light, thermal, or 
redox initiated processes (Figure 1.15). 
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Figure 1.15 – Radical Initiation Systems: Examples of light (using benzoyl peroxide), thermal 
(using AIBN), and redox (using hydrogen peroxide and iron II) initiated systems. 
 
Thiol-ene reactions are advantageous because of their selectivity, speed, and tolerance of 
various thiols and alkenes.105 Additionally, thiol-ene reactions can be implemented with a 
multitude of thiols and alkenes (Figure 1.16). These reactions have been used in a wide variety of 
applications, such as micropatterned hydrogels, due to their ability to incorporate multiple 
functional groups and limited side reactions.106 
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Figure 1.16 – General Initiation and Propagation Steps: The general thiol-ene reaction scheme 
showing the radical transfer from initiator to free thiol, and subsequent chain propagation of 
using carbon and sulfur radicals. 
 
Thiol-ene reactions have been used to create polymers with complex structures and sites 
of multiple functionalities. For example, using a thiol-ene reaction, a polyethylene glyclol 
methacrylate copolymer was grafted onto a polyurethane surface.107 Additionally, because of their 
tolerance and efficiency, thiol-ene reactions have also been used in various biological applications. 
Thiol-ene reactions were used as a method to tag proteins to various surfaces.108 As more was 
discovered about the thiol-ene reactions, they began being used as crosslinking reactions to form 
hydrogels. These hydrogels were then used as 3D matrices for cell culture of various cells such as 
human liver,109 epithelial,110 intestinal,111 and embryonic cells.112 
 
1.6 Thiol:Norbornene 
 
With the concept of chemical crosslinks and the thiol-ene reactions used to create them in 
mind, the concept of a “thiol to norbornene ratio,” or T:Nb comes into play. The thiol:norbornene 
is the ratio of free thiols (–SH) to carbon-carbon double bonds present on the norbornenes. 
Norbornenes are used because they generally have the highest ene reactivity when compared to 
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other available alkenes.113 Furthermore, norbornenes have been shown to be the most reactive 
alkenes specifically within thiol-ene reactions.114 
The T:Nb can be calculated using the moles of crosslinker and norbornene but, like the 
total wt% and CNF %, is more often a variable that is controlled. As a result, the T:Nb is chosen 
prior to creating hydrogels, and the formulations are adjusted to include the appropriate amounts 
of crosslinker. Even more complex is the fact that the crosslinkers used are dithiols. Consequently, 
there are two free thiols available for reactions on each crosslinker. On the other hand, because 
each norbornene molecule only contains one carbon-carbon double bond, the norbornenes only 
have one site of functionality available for reactions. The differing number of reactive sites is 
imperative for the thiol-ene reactions to create effective crosslinks. For example, if a monothiol 
were used, there would be thiol-ene reactions between the free thiols and the norbornene groups, 
but once a thiol had reacted there would be no additional thiol available to react with another 
norbornene, thus making it ineffective (Figure 1.17). With the requirements for creating effective 
crosslinks in mind, there exist three distinct situations: T:Nb = 1, T:Nb < 1, and T:Nb >1. 
 
Figure 1.17 – Thiol-ene Reactions Using Dithiols vs Monothiols: A schematic representation of 
the thiol-ene reactions between norbornene groups and either dithiols (red) or monothiols 
(brown). 
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Perhaps the easiest case to visualize, a T:Nb of 1 means that for every free thiol, there is 
an available norbornene to react with. Theoretically, a hydrogel made with a T:Nb = 1 would be 
composed of 100% effective crosslinks (Figure 1.18). More specifically, these hydrogels would 
have undergone all potential reactions to create effective crosslinks; meaning every carbon-carbon 
double bond from every norbornene reacted with every free thiol present. As a result of the 
formation of the maximum number of effective crosslinks, these hydrogels are expected to swell 
the least amounts, possess the highest moduli, exhibit the least degradation. 
 
Figure 1.18 – A T:Nb = 1 Crosslinking Reaction: A schematic representation of the crosslinking 
reaction between NorCMC (blue) and a dithiol crosslinker (red) when the T:Nb = 1. 
 
As one of the ends on the spectrum of T:Nbs, the case of a T:Nb < 1 can be visualized 
similarly to the case of T:Nb = 1. In T:Nb < 1 situations, the dithiol crosslinkers act as the limiting 
reagents, while the norbornene functionalized chains are present in excess. Subsequently, the 
hydrogel networks created under these conditions contain fewer crosslinks than possible (Figure 
1.19). As a consequence of containing fewer effective crosslinks than other T:Nbs, hydrogels made 
using T:Nbs < 1 are expected to exhibit higher swelling percentages, lower moduli, and more 
network degradation over time when compared to hydrogels made using T:Nb = 1. 
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Figure 1.19 – A T:Nb < 1 Crosslinking Reaction: A schematic representation of the crosslinking 
reaction between NorCMC (blue) and a dithiol crosslinker (red) when the T:Nb < 1. 
 
Hydrogels made with T:Nbs < 1 still have a variety of uses; for example, using a lower 
T:Nb could be a solution to obtain the target average swelling percentage. Another potential 
rationale for using a T:Nb < 1 could be in a situation where the norbornene groups were required 
for multiple reactions. More specifically, hydrogels created using a T:Nb < 1 would contain 
crosslinks to hold them together, but the small molecule functionalization could still occur because 
norbornene sites remained available (Figure 1.20). 
 
Figure 1.20 – Small Molecule Functionalization Using T:Nb < 1: A schematic representation of a 
hydrogel made using a T:Nb < 1 that could then have its unreacted norbornene sites 
functionalized using a small molecule (left) compared to a hydrogel made using a T:Nb = 1. 
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Contrary to the T:Nb < 1 situation, if the T:Nb > 1 the norbornene functionalized chains 
would become the limiting reagents and the dithiol crosslinkers present in excess. While effective 
crosslinks will form, there will also be the formation of ineffective crosslinks, most notably in the 
form of dangling ends, throughout the networks (Figure 1.21). Like the T:Nb < 1 hydrogels, the 
T:Nb > 1 hydrogels are expected to exhibit higher swelling percentages, lower moduli, and more 
network degradation over time when compared to hydrogels made using T:Nb = 1. The results of 
using formulations where the T:Nb > 1 can be seen in the various types of data collected from 
these hydrogels. For example, when considering the compression data from hydrogels made using 
various CMC derivatives, hydrogels made using T:Nbs > 1 actually exhibited lower compression 
moduli than those made using T:Nb = 1 formulations.115,116 However, using a T:Nb > 1 poses 
potential advantages in situations where dangling ends are desired. In the case of using dithiols, if 
free thiol functionality was desired within the networks, having some of the crosslinkers only react 
on one end would leave free thiols available for further modification. 
 
Figure 1.21 – A T:Nb > 1 Crosslinking Reaction: A schematic representation of the crosslinking 
reaction between NorCMC (blue) and a dithiol crosslinker (red) when the T:Nb > 1. 
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1.7 Interpenetrating Networks (IPNs) 
 
Hydrogels made using both CMC and CNF consist of what are known as interpenetrating 
networks or IPNs. Two classifications of IPNs exist: simultaneous and sequential. IPNs are 
considered simultaneous if both polymer networks are formed at the same time, independent of 
each other. On the other hand, sequential IPNs require separate steps for each component of the 
IPN. Initially one of the networks forms and following its formation the other may be formed. 
Typically, the first network is swollen and monomer, crosslinker, and initiator are added to begin 
the second polymerization.117 More specifically, for the case of hydrogels made using NorCMC 
and CNF, because the synthesis of these hydrogels sees both networks being created at the same 
time, these are considered simultaneous IPNs. 
Previously, IPNs have been created using various polysaccharides such as chitosan,118,119 
alginate,120,121 and even CMC.122,123 Polymers containing specific functional groups have also been 
utilized for their various functions in IPNs. Polymers with carboxylic acid functionality such as 
poly(acrylic acid) (PAA)124,125 or poly(methacrylic acid) (PMMA)126,127 have been used, as well 
as polymers with amine functional groups128 and cationic centers containing quaternary 
ammonium groups.129 The main advantage of using IPNs lies within the unique properties that 
each polymer brings to the table individually. The idea behind utilizing IPNs is to retain specific, 
desirable properties from the first polymer network, while adding new properties from the second. 
As a result, many IPNs retain properties from both individual polymer networks, but also exhibit 
new properties that are unique to the IPN itself.130 
The idea of creating an IPN is easier said than done. To begin, many polymers are not 
soluble within each other, nor are they soluble in the same solvents. This obstacle must be 
overcome in order to have either simultaneous or sequential polymerizations. One of the ways to 
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combat this issue is to use crosslinks. If polymers can be crosslinks into networks where they are 
forced to remain together, the compatibility of the different polymers with each other or different 
solvents becomes a nonissue. Yet another complexity of creating IPNs is the tolerance and 
compatibility of the solvents, crosslinkers, and initiators within the systems. If a simultaneous IPN 
is desired, the two polymerizations must be able to occur both accurately and at the same time. 
This requires a certain level of tolerance from each system for the other. Similarly, in the situation 
where a sequential IPN is desired, the second reaction must be able to occur following the first, 
and it cannot undo or alter the first unfavorably. 
A large class of IPNs focus on the improvement and amplification of hydrogel mechanical 
properties. This is such a huge advantage because hydrogels are often very soft and brittle 
materials. While the softness and low moduli of the hydrogels can make them ideal for mimicking 
some tissues and biological media, it can also be a setback and limitation in other applications such 
as coatings or the mimicking of tissues that exhibit higher moduli. Variables such as crosslink 
density and copolymerization have been used to troubleshoot these downfalls, but unfortunately 
have their own setbacks, such as limited or reduced transparency or hydrophobicity; as a result, 
the idea of what are known as “double networks” has risen to prominence.131 Here, rather than 
compromising one valuable property for another, another entire network is added instead. The 
addition of the second network allows for these IPNs to maintain their original desirable properties 
such as hydrophobicity or transparency, and simultaneously reinforce their structure by adding the 
second network. 
The versatility of IPNs has been utilized within hydrogels for cell culture. 3D cell culture 
of chondrocytes within hydrogels containing IPNs showed promise as cell scaffolds when they 
exhibited decreased inflammation and increased protein synthesis.132 Another study showed the 
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improvement of mechanical properties within hydrogels made using IPNs, without the typical 
decrease in conductivity or stretching ability observed when these properties are enhanced.133 
Further studies revealed that hydrogels containing IPNs could also be used as very successful drug 
delivery systems.134 The mechanical strength of these hydrogels was improved by adding a second 
network, while the light transmittance and water uptake of the first network were maintained and 
unaffected by the addition of the second network. These studies and their findings, along with 
many more alike, have made these IPNs front runners in the applications for cell culture and tissue 
generation. 
 
1.8 Human Mesenchymal Stem Cells (hMSCs) 
 
As a type of cell that can differentiate into other cell types, mesenchymal stem cells (MSCs) 
have become key components in a variety of applications. MSCs were first discovered in 1968 by 
A.J. Friedenstein, when the cells he was studying exhibited similarities to fibroblasts and showed 
a tendency to replicate rapidly and form colonies.135 These cells were classified as a colony 
forming unit-fibroblast (CFU-F), with further investigation showing that they were able to 
differentiate into various cell types.136 These cells were classified as stem cells because they were 
self-sustaining, replicating, and able to differentiate into multiple lineages.137 As their name 
suggests, human mesenchymal stem cells (hMSCs) are derived from humans, and can differentiate 
into a multitude of cell types. 
As a result of their function to differentiate into various cell types, it is imperative that 
hMSCs are able to move and congregate to locations throughout the body.138 Investigation of MSC 
membranes has shown the presence of molecules used for surface adhesion,139 while more specific 
studies have shown that hMSCs bind to endothelial cell adhesion molecules.140 After becoming 
bound to the surfaces of various cells, hMSCs can travel through the body and relocate to sites of 
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demand. hMSC movement can be local, meaning cells move to or within a single organ or part of 
the body, or systemic, meaning cells move are throughout the body.141 
Because they can differentiate into many different cell types and can therefore be required 
at in an assortment of places within the body, hMSCs rely heavily on cell-cell communication. Not 
only must hMSCs communicate with each other to organize, grow, and proliferate, but they must 
also communicate with other cell types for differentiation purposes. Studies observing hMSCs 
only have revealed that they prefer cell to cell contact, with other observations reporting cells 
fusing together to form a larger cell, and then breaking apart and dividing on their own.142 
Additionally, in terms of growth and proliferation, it has been shown that hMSCs prefer to be at 
the same stages as their neighboring counterparts.143 On top of cell-cell communication amongst 
themselves, hMSCs must also be able to communicate with other types of cells. This 
communication is vital for the purposes of growth, sustainment, and proliferation, as well as the 
necessity to congregate and differentiate appropriately. hMSCs are drawn to areas of the body in 
need of upkeep or repair, meaning that communication with other cell types is imperative for 
finding target locations and performing the necessary functions. 
hMSCs have a more complex cell cycle than most because they must be able to proliferate 
and differentiate. Proliferation is important because hMSCs must have a method for replication 
that yields other multipotent stem cells. Differentiation is important because hMSCs function to 
maintain and replace specialized cells throughout the body. The proliferation of hMSCs is 
mediated by various growth factors, such as fibroblast, epidermal, and insulin-like growth 
factors.144,145 Additionally, fibroblast growth factors (FGFs) not only influence cell proliferation, 
they also affect the lineages that cells go down.146 hMSC proliferation can be triggered by a vast 
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number of growth factors, environmental changes, and signals. Cell fate has also been linked to 
several environmental factors such as cell shape,147 the extracellular matrix,148 and modulus.149 
While the concept of differentiating into different cell types makes hMSCs very attractive 
for use in a variety of applications, there are some caveats that come with using these versatile 
cells. The first challenge associated with utilizing hMSCs is obtaining them. hMSCs are most 
commonly collected from human bone marrow.150 However, despite the most common extraction 
site for hMSCs being bone marrow, hMSCs have been obtained from other areas of the body such 
as adipose tissue,151 skeletal muscle,152 synovium,153 and even the umbilical cord.154 While these 
other hMSC extraction sites do exist and have been show to retrieve reliable hMSCs, bone marrow 
has remained the most common extraction area for hMSCs due the fact that removal is the least 
invasive.155 
Once a method of harvesting hMSCs has been determined, another drawback of using 
hMSCs concerns the correlation between their age and ability to differentiate. As with any cell 
type, the threat of mutations and their potentially negative effects remains present in each and 
every cell. hMSCs contain what are known as hub genes, whose specific function is to reduce or 
minimize the negative effects caused by genetic mutations.156 Despite being useful in the way that 
they remove and reduce the negative side effects caused by mutations, hub genes can also cause 
oxidative stress to the cells, which in turn can cause loss of function and eventual death. hMSCs 
from earlier divisions have been shown to have more effective checkpoints when it comes to 
regulation of DNA replication.157 As a result of this, older MSCs are more likely to experience 
DNA damage and replication errors. Studies have also shown that as hMSCs age, their migration 
decreases, and they lose their ability to differentiate as readily into various cell types.158 Once an 
hMSC has become too old or damaged to function properly, autophagy is used to eliminate it.159 
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The combination of added oxidative stress, increased potential for DNA damage and mutations, 
and decreased differentiation abilities make older hMSCs undesirable for various studies and 
applications. 
Despite the challenges and concerns associated with using hMSCs, they have been widely 
and successfully employed in many applications. A main advantage of using MSCs is that they 
can be incorporated into a system without being destroyed by an immunoresponse, regardless of 
whether they come from the same person (autologous) or a donor (allogenic).160 Arguments for 
the autologous method consider that stem cells taken from the patients themselves pose less of a 
risk when reintroduced. Conversely, the allogenic method presents advantages when it comes to 
cell availability and patient procedures.161 Regardless of the method employed, hMSCs have been 
utilized in numerous treatments for conditions such as osteonecrosis,162 lung disease,163 and 
osteoarthritis,164 as well as to promote various kinds of cell growth and proliferation such as 
angiogenesis.165 
One widely used method for studying hMSCs is incorporating them into hydrogels. 
Hydrogels are incredibly valuable materials when it comes to growing cells because their 3D 
nature helps cells retain their shape.166 One study performed using hydrogels showed that stiffer 
hydrogels supported osteogenesis, while softer hydrogels encouraged adipogenesis.167 As a result, 
hMSCs have been grown under various conditions in numerous hydrogel environments to examine 
their growth, proliferation, and differentiation. Regardless of the specific culturing methods, 
hMSCs are particularly interesting to study because there are so many factors that influence their 
fate. 
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1.9 Research Objectives 
 
Chemical crosslinks can be used to control the number of effective crosslinks within a 
system, and therefore dictate modulus. The chemical crosslinks formed within NorCMC hydrogels 
can also be used to control CNF content within hydrogels. Due to the CNF entanglement with both 
itself and the NorCMC, this IPN consists of two polymer networks, one maintained by chemical 
crosslinks, and the other by physical. 
The IPN consisting of NorCMC and CNF is a great example of keeping desirable properties 
such as higher moduli by incorporating reinforcing agents; using NorCMC allows for the 
formation of the hydrogel via chemical crosslinks, but also allows a significant portion of the 
swelling and solubility within water to occur. The addition of the CNF into the network provides 
increased mechanical strength and added complexity to the networks. As a result, these IPNs have 
moduli on the kPa scale, while the CNFs themselves have moduli on the GPa scale. 
Specific to this research, CNF is desirable to use within hydrogels because it is similar to 
collagen in terms of size, shape, and modulus,168 but does not interact with the hMSCs chemically. 
Instead, any differentiation observed within the hMSCs could be attributed to a purely physical 
environment. Understanding how to control network structure and function is imperative for 
designing new materials. For this research specifically, by fine-tuning variables such as T:Nb, total 
wt%, and CNF % of total polymer in the system, the moduli of hydrogels can be set and remain 
consistent. With a consistent modulus, the role that CNF % has on cell fate can be explored (Figure 
1.22) Furthermore, the target moduli of 10 and 100 kPa were chosen because they were an order 
of magnitude different, and soft tissues contain moduli around 10 kPa, while cardiac muscle 
exhibit moduli of approximately 100 kPa.169 
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Figure 1.22 – Differentiation of hMSCs Using Various Hydrogels: A schematic representation of 
hMSCs differentiating into numerous cell types as a result of being incorporated into hydrogels 
possessing different properties. 
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CHAPTER 2 
Chapter 2. Experimental Methods 
EXPERIMENTAL METHODS 
 
2.1 General Materials and Methods 
 
The chemicals used were purchased from Sigma-Aldrich, TCI Chemicals, and Fisher 
Scientific and did not undergo any purification or altering unless specified. Reagents and samples 
were massed using a Sartorius Practum 64-1s analytical balance (precision ± 0.1 mg). The 1H 
nuclear magnetic resonance (NMR) spectra and all the associated data were obtained using a 
Bruker 500 MHz Instrument, using 99.8% deuterium oxide (D2O) as a solvent. The UV-Vis 
spectroscopy data were obtained using a Beckman DU 7500, diode array UV/VIS 
spectrophotometer. Compression testing was performed with a compression fixture using dynamic 
mechanical analysis (DMA) (Q8000 Thermal Analysis). The hydrogels were crosslinked using an 
Omnicure S1000 UV lamp, with wavelengths ranging from 320-390 nm, but the main emission 
being at 365 nm. 
 
2.2 Synthesis of Norbornene-Modified Carboxymethyl Cellulose (NorCMC) 
 
Carboxymethyl cellulose (CMC) was used as the original polymer onto which reactive 
norbornene groups were attached. Sodium carboxymethyl cellulose (NaCMC) containing 70% 
carboxylation functionality per anhydroglucose repeat unit and an average MW of 90,000 g/mol 
was obtained from Sigma Aldrich and used as received. The reaction was performed on a 5 g scale 
using a 1000 mL round bottom flask. Prior to beginning the reaction, 4.5077 g NaCMC were 
dissolved into 446 mL reverse osmosis water (ROW) at room temperature, to make a 1 wt% 
NaCMC solution. Once homogenous, 2.6650 g (13.9 mmol) 1-ethyl-3-(3-dimethylaminopropyl) 
carboiimide (EDC) and 1.605 g (13.9 mmol) N-hydroxysuccinimide (NHS) were added 
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respectively and allowed to dissolve. Following this, 1.78 mL (14.4 mmol) 5-norbornene-2-
methylamine (NA) were added, clouding the solution and giving it a yellow-green tint. The 
solution then stirred at room temperature, for approximately 18 hours. By the end of the reaction, 
the solution had remained cloudy and developed a more prominent green tint. 
Once the reaction was complete, 7.5 g (0.13 mol) sodium chloride (NaCl) was added and 
the solution stirred for 30 minutes. During this time, 3 L acetone was chilled using ice, and the 
precipitation apparatus was prepared. Following the addition of NaCl and 30-minute stir, the 
NorCMC solution was transferred into a 500 mL separatory funnel and added dropwise into the 
cold acetone. Upon introduction to the cold acetone, the NorCMC solution immediately began 
forming white, stringy precipitates. A stir bar was placed in the acetone, keeping the already 
precipitated NorCMC particles moving in solution for the duration of the precipitation. Eventually 
the precipitates congregated and formed large, dense clusters of chains. Once all of the NorCMC 
had been precipitated, the acetone solution was added to a 600 mL fritted glass funnel filter and 
vacuum filtered to separate the solid NorCMC precipitate from the acetone. Following the 
separation, the NorCMC was added to approximately 300 mL ROW and stirred until dissolved. 
The 300 mL solution was then added to Fisherbrand dialysis bags with a molecular weight cut off 
(MWCO) of 6,000-8,000 Da. The dialysis bags were then placed into 4 L beakers containing 
ROW. These beakers contained stir bars that maintained weak to mild stirring to promote diffusion 
of small molecules out of the dialysis bags and into the surrounding ROW. The ROW was changed 
twice daily for three days, yielding a total of six water changes. At the end of this period the 
contents of the dialysis bags were frozen in ice cube trays. Once frozen, the ice cubes were 
removed and added to 600 mL Labconco lyophilization flasks. These flasks were then introduced 
to a Labconco FreeZone 4.5 lyophilizer, where they would freeze-dry for a minimum of seven 
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days. Following lyophilization, the NorCMC samples were placed into plastic bags and stored at 
-20 °C in a laboratory freezer. 
The percentage of dry NorCMC within the samples was also determined. Following 
lyophilization, three NorCMC samples were taken, each approximately 10 mg, and each placed 
into a 4 mL scintillation (1 Dram) vial. The vials were then dried in a Fisherbrand vacuum oven, 
kept at 100 °C, for three days. After three days, the samples were massed again, and the percentage 
of dry NorCMC within the original sample was determined. 
 
2.3 Characterization of Norbornene-Modified Carboxymethyl Cellulose (NorCMC) 
 
After lyophilization, NorCMC samples were analyzed using 1H NMR spectroscopy to 
determine the norbornene functionalization. The samples were prepared by dissolving 
approximately 10 mg NorCMC into 650 µL D2O. The samples were given a delay time of 2 
seconds and spectra were obtained using 64 scans. Mestrenova software was used to analyze the 
retrieved spectra. The spectra were referenced to the D2O solvent peak (found at 4.79 ppm), with 
the alkene (approximately 6.22 to 5.97 ppm), norbornene bridge (approximately 1.36 to 1.24 ppm), 
and CMC backbone protons (approximately 4.5 to 3.0 ppm) also labelled. 
The alkene integration represents the 2 protons associated with the alkene of the attached 
norbornene. The CMC integration is more complicated because it represents fractions of two 
components at play within the CMC repeat units. First, approximately 70% of the initial CMC 
repeat units contain a carboxymethyl group, which would contribute 9 protons. However, 30% of 
the initial CMC repeat units do not contain carboxymethyl groups, and are instead cellulose, 
contributing 7 protons. With this information, it can be approximated that the CMC integration 
represents an average of 8.4 protons. The integrations of the alkene and CMC backbone protons 
were then normalized using Equations 2.1 and 2.2 respectively, where IA and ICMC are the 
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integration regions of the alkene and CMC peaks respectively, PA and PCMC are the number of 
protons represented by the alkene and CMC peaks respectively, and HA and HCMC are the 
normalized alkene and CMC integrations respectively. Then, using the normalized alkene and 
CMC integrations, the percent functionalization of each sample was calculated using Equation 2.3. 
 
(
IA
PA
) = HA Equation 2.1  
Equation 1.1 – Normalized Alkene Integration 
(
ICMC
PCMC
) = HCMC Equation 2.2 
Equation 2.2 – Normalized CMC Integration 
(
HA
HCMC
) ∙ 100 = % Functionalization Equation 2.3  
Equation 3.3 – Percent Functionalization 
After the functionalization was determined, the percentage of dry NorCMC within the 
sample was calculated using Equation 2.4, where MI is the initial sample mass following 
lyophilization, and MF is the sample mass following vacuum and oven drying for three days. 
 
(
MF
MI
) ∙ 100 = % Dry NorCMC Equation 2.4 
Equation 4.4 – Percentage of Dry NorCMC 
The % dry NorCMC was calculated for each individual sample, and the three calculated 
values were then averaged, and a standard deviation was found. This average % dry NorCMC 
value was calculated for each batch of NorCMC and used to calculate the masses of NorCMC to 
be used within hydrogels. 
 
2.4 Synthesis of UV Light Initiated Hydrogels 
 
2.4.1 Synthesis of NorCMC Hydrogels 
 
Before adding CNF or cells, a series of baseline hydrogels were made using NorCMC only. 
Synthesis of these hydrogels began with dissolving NorCMC into a phosphate buffer saline (PBS) 
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(pH = 7.4) within either a 1.5 or 2 mL microcentrifuge tube. To promote fast and homogenous 
solvation, the NorCMC and PBS were vortexed. During this time, a stock solution of dithiol 
crosslinker was created. Dithiothreitol (DTT) was vortexed with PBS to create 1 M stock solutions 
made fresh every day that hydrogels were synthesized. Once the NorCMC had completely 
dissolved within the PBS, the appropriate volume of DTT stock solution was added to reach the 
target T:Nb and the solution was then vortexed once more. During this time, radical initiator 2-
hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (I2959) was dissolved into PBS and used 
to create a 0.5 wt% stock solution. This solution was made only once and covered using aluminum 
foil to shield it from the light. The I2959 stock solution was stored at room temperature and made 
on an as needed basis. After vortexing the NorCMC/PBS/DTT solution, the appropriate volume 
of the I2959 stock solution was added to give the hydrogel solution a final concentration of 0.05 
wt% I2959. The microcentrifuge tube was then covered with aluminum foil and vortexed. After 
vortexing, the solutions were centrifuged in an Eppendorf centrifuge for 6 to 10 minutes depending 
on volume to remove air bubbles. As centrifugation was happening, the lamp was then calibrated. 
Using a light guide, the lamp’s height and intensity were adjusted to give a power of approximately 
10±0.1 mW/cm2. These baseline hydrogels contained only NorCMC, making them transparent. 
Once the solutions were prepared, a 200 µL micropipette was used to add the solution in 
50 µL partitions to precut 1 mL syringes. Once the solutions were added, any remaining air bubbles 
were removed, and the tops of the syringes were sealed with glass coverslips to prevent the 
introduction of air or potential development of bubbles. The syringes were then placed underneath 
the lamp and irradiated for 60 seconds. After 60 seconds, the hydrogels had formed and were 
gently pushed out the syringes. The hydrogels were then placed into individual wells within 24-
well plates, where 1 mL PBS was added, and stored in an incubator at 37 °C. 
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2.4.2 Synthesis of NorCMC Hydrogels with the Incorporation of CNF 
 
CNF was incorporated into the NorCMC hydrogels in the first step of the hydrogel solution 
preparation. In addition to adding NorCMC to the PBS, a CNF distribution (2.86 wt% CNF) was 
also added and the three were vortexed until the NorCMC had dissolved. The CNF did not dissolve 
but became more evenly dispersed with the vortexing. The crosslinker and UV radical initiator 
addition steps otherwise mirrored the synthesis of hydrogels made using NorCMC only. The 
calibration of the lamp required premade CNF solutions that would be placed in a mold above the 
light guide. These solutions were used to ensure that the power reaching the bottom most portion 
of the syringes had a power of 10 mW/cm2, and therefore power was consistent between samples. 
 
2.4.3 Varying Hydrogel Formulations 
 
The hydrogels synthesized owe their tunable properties to the potential variation of many 
elements within these solutions. Initially, the irradiation time used for the hydrogels was varied to 
determine the optimal irradiation time to model the subsequent experiments after. Following this, 
the NorCMC hydrogels made without CNF were made varying both thiol:norbornene (T:Nb) and 
total wt%. The addition of CNF allowed variation in both NorCMC and CNF wt%s, total wt%, 
and % CNF. To create a large CNF % sweep, hydrogels were made using different T:Nbs, total 
wt%s, and CNF %s. The hydrogels were made using T:Nbs of 0.25, 0.5, 0.75, or 1 and total wt%s 
of 2, 3, or 4 wt%. Lastly, the hydrogels were made using CNF %s of 0, 10, 30, or 50% CNF.  
 
2.5 Hydrogel Swelling Studies 
 
Immediately following synthesis and prior to the addition of PBS, hydrogels were massed, 
giving the initial hydrogel masses (MI). The hydrogels were placed in individual wells of 24-well 
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plates, and 1 mL PBS was added to each well. The well plates were then placed in the incubator 
at 37 °C, where they remained for 24 hours. After 24 hours the hydrogels were removed from their 
wells, excess PBS was carefully removed from the hydrogels using a Kimwipe, and then the 
hydrogels were massed, giving the final mass of the hydrogels (MF). The swelling percentage for 
each hydrogel was calculated using Equation 2.5, where MI is the initial mass of the hydrogel, and 
MF is the final. The swelling percentage was calculated for every hydrogel, and then average 
swelling percentages and standard deviations were calculated and reported. 
 
(
MF − MI
MI
) ∙ 100 = Swelling Percentage Equation 2.5 
Equation 5.5 – Swelling Percentage 
2.6 Compression Testing 
 
Compression testing was used to measure the compression moduli of the hydrogels. 
Hydrogels were synthesized using the correct formulations and then incubated and swollen for 24 
hours. The same hydrogels used for swelling studies were then used for compression testing. 
Compression testing was performed at approximately 25 °C, and each hydrogel was used for only 
one measurement. The strain rate was 10% per minute, increasing to 30% total strain after 3 
minutes. The compression moduli measurements were recorded as the slopes of the stress/strain 
curve over the interval of 10 to 20% strain. Following compression testing, the average 
compression moduli and standard deviations of each formulation (n ≥5) were determined. 
 
2.7 Degradation Assays for Quantification of NorCMC and CNF 
 
2.7.1 Degradation Assays for NorCMC and CNF Quantification 
 
Degradation studies were used to quantify the amount of NorCMC lost from the hydrogels 
over time. After the hydrogels had been prepared and stored in 1 mL of PBS at 37 °C for 24 hours, 
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the PBS was extracted and saved in a microcentrifuge tube. Fresh PBS then replaced the old, and 
the hydrogels were stored under the same conditions for seven days. After one week, the same 
procedure was used to extract and replace the PBS. This process was repeated, and PBS samples 
were collected after 1, 7, 14, 21, and 28 days. 
To make the solution used to breakdown and quantify the NorCMC and CNF, 2,7-
dihydroxynaphthalene (DHN), from Sigma Aldrich, and concentrated sulfuric acid, from Fisher 
Scientific, were used as received. Using the analytical balance, 0.125 g DHN was massed and 
dissolved in approximately 50 mL of concentrated sulfuric acid. This solution was diluted with 
more concentrated sulfuric acid in a 250 mL volumetric flask (precision ±0.02 mL). The solution 
was then placed in the oven at approximately 40 °C for four hours, and then stored in a laboratory 
refrigerator at 2 °C. 
Stock solutions of NorCMC standards were made before the DHN-sulfuric acid solution 
was added to any samples. To begin, 0.0250 g of NorCMC was dissolved in PBS, using a 25 mL 
volumetric flask, to create a 1 mg/mL NorCMC solution. Using this initial solution, serial dilutions 
were performed to give 0.5, 0.25, 0.125, 0.0625, 0.03125, and 0.015625 mg/mL stock solutions. 
A solution containing only PBS served as the 0 mg/mL standard. All standards were stored in a 
laboratory refrigerator at 2 °C. 
The standards used for the assays contained 0.25 mg/mL concentration or less because this 
was greater than the concentrations collected from the samples. Additionally, to ensure accuracy, 
these standards were run each day the assays were performed. Using a 20-200 µL micropipette, 30 
µL of each of the standards and extracted samples were added to new borosilicate disposable 
culture tubes. Following this, using a 1000 µL micropipette, 970 µL of the DHN-sulfuric acid 
solution was added to each sample. The solutions were mixed by swirling the tubes, and then 
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placed in an empty glass drying oven (approximately 100 °C) for two hours. After the two hours, 
the solutions were removed from the oven and allowed to cool to room temperature for 
approximately 15 minutes. Once at room temperature, the solutions were prepared for analysis via 
UV-Vis spectroscopy by being transferred into Fisherbrand disposable polystyrene cuvettes. 
During the final extraction, after the PBS had been removed, the hydrogels were also 
removed and degraded. New NorCMC standards were made by dissolving 0.1003 g of NorCMC 
in 2.4 mL of PBS. The NorCMC was massed using the same balance mentioned above, and the 
PBS was measured using the 1000 µL micropipette. These standards were made based on wt% 
rather than concentration, with the first solution being 4 wt% NorCMC. Serial dilutions were then 
used to make 2 and 1 wt% NorCMC standard solutions. These were stored in the laboratory 
refrigerator at 2 °C. Before placing the hydrogels into new borosilicate disposable culture tubes, 
they were first massed, followed by being cut with a razorblade. The hydrogels used were massed, 
and cut to be approximately 0.0200 g. Using the mass of the hydrogels as a reference, 20 µL of 
each standard was added to new borosilicate disposable culture tubes. Following this, 1 mL of 
concentrated sulfuric acid was added to each standard or sample and left to react for an hour at 
room temperature. After sitting for an hour, 2 mL of PBS was added to each tube and swirled to 
mix. Then, using new tubes, 30 µL of each solution was mixed with 970 µL of the DHN-sulfuric 
acid solution, and the samples were evaluated as previously described. 
Akin the NorCMC degradation studies described above, the CNF loss from the hydrogels 
was also quantified. The same samples used for the NorCMC analyses were used to quantify CNF, 
but once the DHN-sulfuric acid solution was added, these solutions were left in a 100 °C oven for 
24 hours before being analyzed as previously described. 
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2.7.2 Calculation Combined Polymeric Losses 
 
To obtain an overview of the total polymeric losses from each hydrogel, and the portion of 
these losses attributed to NorCMC or CNF, calculations were performed using the previously 
obtained NorCMC and CNF degradation data. The theoretical initial masses of NorCMC 
(MI,NorCMC) and CNF (MI,CNF) were calculated using Equations 2.6 and 2.7 respectively, where V 
is the total volume of an individual hydrogel, WNorCMC is the wt% of NorCMC, and WCNF is the 
wt% of CNF. 
MI,NorCMC =
(V ∙ WNorCMC)
100
 Equation 2.6 
Equation 6.6 – Theoretical Initial Mass of NorCMC 
MI,CNF =
(V ∙ WCNF)
100
 Equation 2.7 
Equation 7.7 – Theoretical Initial Mass of CNF 
Using the theoretical initial masses of NorCMC and CNF, the masses of NorCMC 
(ML,NorCMC) and CNF (ML,CNF) lost were calculated using Equations 2.8 and 2.9, where PNorCMC 
and PCNF are the experimentally determined percentages of NorCMC and CNF lost respectively. 
ML,NorCMC = MI,NorCMC ∙ (
PNorCMC
100
) Equation 2.8 
Equation 8.8 – Mass of NorCMC Lost 
ML,CNF = MI,CNF ∙ (
PCNF
100
) Equation 2.9 
Equation 9.9 – Mass of CNF Lost 
The percentages of NorCMC (PL,NorCMC) and CNF (PL,CNF) lost from the total polymeric 
materials were calculated using Equations 2.10 and 2.11 respectively. The total percentage of 
polymer lost (PL,Total) was then calculated using Equation 2.12. 
PL,NorCMC =
ML,NorCMC
MI,NorCMC + MI,CNF
 Equation 2.10 
Equation 10.10 – Percent of NorCMC Lost from Total Polymeric Material 
PL,CNF =
ML,CNF
MI,NorCMC + MI,CNF
 Equation 2.11 
Equation 11.11 – Percent of CNF Lost from Total Polymeric Material 
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PL,Total = PL,NorCMC + PL,CNF Equation 2.12 
Equation 12.12 – Percent of Polymer Lost 
These calculations were performed for each individual hydrogel, and the percentages were 
used calculate averages and standard deviations (n ≥2) of each formulation. 
 
2.8 Calculation of Effective Crosslink Density 
 
The effective crosslink density (ve) of each hydrogel was calculated using Equation 2.13, 
where E is the compression modulus, φ𝑒 is the final volume fraction of polymer after swelling, R 
is the gas constant (8.314 L·kPa/mol·K) and T is room temperature (298.15 K). 
 
ve =
E
3φe
1
3RT
 
Equation 2.13 
Equation 13.13 – Effective Crosslink Density 
The volume fraction of polymer was calculated using Equation 2.14, where φI is the initial 
volume fraction before swelling, and r is the volume ratio between the initial and final diameters 
cubed. 
 
φe = φIr Equation 2.14 
Equation 14.14 – Volume Fraction of Polymer 
The initial volume fraction was calculated using Equation 2.15, where VC is the volume of 
cellulose and VS is the volume of solvent, in this case, water. The initial volumes of both polymer 
and solvent were calculated using Equations 2.16 and 2.17 respectively, where MC and MS are the 
known masses of the NorCMC and PBS respectively, and ρC and ρS are the densities of cellulose 
(1.5 g/mL) and water (1 g/mL) respectively. 
 
φI =
VC
VC + VS
 Equation 2.15 
Equation 15.15 – Initial Volume Fraction of Polymer 
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VC =
MC
ρC
 Equation 2.16 
Equation 16.16 – Initial Volume of Polymer 
VS =
MS
ρS
 Equation 2.17 
Equation 17.17 – Initial Volume of Solvent 
The volume ratio was calculated using Equation 2.18, where dI and dF are the initial and 
final diameters respectively. Because the hydrogels were all made using the same syringe molds, 
the initial diameter was measured to be 3.99 mm for all hydrogels, and the final diameters of each 
individual hydrogel were measured prior to compression testing. 
 
r = (
dI
dF
)
3
 Equation 2.18 
Equation 18.18 – Volume Ratio 
The effective crosslink densities were used to calculate averages and standard deviations 
(n ≥5) of each formulation. 
 
2.9 Cell Culture Using hMSCs 
 
Media was made using low glucose Dulbecco`s Modified Eagle Media (DMEM), 10% 
fetal bovine serum (FBS), 1 % Antibiotic-Antimycotic (Anti-Anti), and 100 µg/mL fibroblast 
growth factor (FGF). Cells were deadhered from the cell culture treated petri dishes using 3 mL of 
warm (37°C) 0.05% trypsin/EDTA. 
 
2.9.1 Thawing and Expanding Human Mesenchymal Stem Cells (hMSCs) 
 
Human mesenchymal stem cells (hMSCs) had been previously kept in 1 mL of 
media/DMSO solution, stored in cryovials, and frozen in liquid nitrogen. After retrieving the 
samples, cryovials were thawed in a 37 °C bead bath and then diluted using approximately 5 mL 
of media for every 1 mL of media/DMSO solution. These solutions were then centrifuged at 200 
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× g (0.2 rcf) for 5 minutes, the media/DMSO aspirated off, and then plated onto cell culture treated 
petri dishes with 8-10 mL of media. 
hMSCs were left to reach 90% confluency, which was achieved on average after 7-9 days. 
Once 90% confluent or after 9 days, the cells could be incorporated into hydrogels, or expanded. 
Cells were expanded at 1:8 or 1:10 ratios depending on cell density. To begin thawing, the media 
was aspirated off and the plates were washed with Dulbecco's phosphate-buffered saline (DPBS) 
to remove any excess media and/or debris. After the plates were washed, 3 mL of warm (37°C) 
0.05% trypsin/EDTA was added to each plate and they were placed in the incubator for 5 minutes. 
Once 5 minutes had passed, the trypsin was diluted using 5 mL of media for every 3 mL of 
trypsin/EDTA. The media/trypsin solutions were then transferred equally into two 50 mL conical 
centrifuge tubes and centrifuged at 200 × g (0.2 rcf) for 5 minutes. During the centrifugation, new 
tissue culture plates were prepared by adding 9 mL of media to each new plate. Following 
centrifugation, the media/trypsin was aspirated off, and either 4 or 5 mL (4 mL for a 1:8, 5 mL for 
a 1:10) of media was added the remaining pellets. The pellets were broken up via pipette mixing, 
and 1 mL of the hMSC containing media was added to each of the previously prepared plates. The 
plates were labelled one passage higher than the cells used to expand with and placed back into 
the incubator to allow the cells to grow. 
 
2.9.2 Freezing Human Mesenchymal Stem Cells (hMSCs) 
 
hMSCs were frozen using media containing 10% DMSO. Similar to thawing, the plated 
hMSCs underwent treatment with trypsin and centrifugation. Once the pellets were separated from 
the trypsin/media solution, they were suspended in the media/DMSO solution and added to 
cryovials in 1 mL increments. These cryovials were placed into a Corning CoolCell LX Cell 
Freezing Container, then frozen in a -80 °C overnight, and stored in liquid nitrogen. 
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2.10 Synthesis of Sterile Hydrogels Containing hMSCs 
 
Prior to UV light sterilization, precut glass coverslips, tweezers and spatulas, the base and 
stand with the clamp for the UV light, and open microcentrifuge tubes containing pre-massed 
NorCMC, CNF, and DTT were placed into the biohood. These were irradiated for 5 minutes, and 
then, after flipping the glass coverslips over, irradiated for another 5 minutes. The UV lamp was 
then introduced into the biohood, calibrated using the light guide, and adjusted to the appropriate 
height. DPBS was then added to the NorCMC and CNF microcentrifuge tube, and after being 
sealed in the biohood, the microcentrifuge tube was vortexed until the NorCMC was dissolved and 
the CNF suspended. The DTT and I2959 stock solutions were also made using DPBS, with the 
DTT solutions being made fresh every day, and the I2959 solution made on an as needed basis. 
The cells were then transferred from the incubator and trypsinized from the petri dishes using the 
methods outlined previously. A cell pellet was finally collected in a sterile 1.5 mL microcentrifuge 
tube. The appropriate amount of I2959 solution was added and pellet was then broken up. Once 
all components were ready, the appropriate volumes of DTT and I2959 stock solutions were added, 
and the hydrogels were synthesized using the same methods described previously. 
 
2.11 Live/Dead Assay for Cell Viability 
 
Following the incorporation of hMSCs into the various hydrogels, cell viability studies 
were conducted using live/dead assays. Cell viability studies were performed after the hydrogels 
had been kept in media for 24 hours. Before adding the stains, the media from each well was 
removed. Then 1 mL of DPBS, 0.25 µL of calcein am, and 1 µL of ethidium homodimer-1 were 
added to each well. The hydrogels were put back into the incubator (37 °C, 5% CO2) for 40 
minutes. Once the incubation was complete, the DPBS was removed and replaced with fresh 
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DPBS. This was incubated for an additional 10 minutes, and then that DPBS was once again 
replaced with fresh DPBS. The hydrogels were then examined using a Zeiss Axio Observer.Z1 
microscope with a motorized stage and Definite Focus. Using the retrieved images, the live and 
dead cells were counted using ImageJ. 
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CHAPTER 3 
Chapter 3. Results and Discussion 
RESULTS AND DISCUSSION 
 
3.1 Synthesis of Norbornene-Modified Carboxymethyl Cellulose (NorCMC) 
 
Following the synthesis of NorCMC (Figure 3.1) the 1H NMR spectra of the NorCMC 
samples (Figure 3.2) confirmed successful purification steps because only broad peaks were 
present. Sharp peaks represent small molecules, such as acetone or norbornene amine, which 
would act as impurities within the NorCMC samples. Water held within the NorCMC was another 
impurity that was corrected for by performing oven drying and subsequent calculations to 
determine the true percentage of NorCMC within samples. This residual water shows up within 
the D2O peak (4.79 ppm), contributing to its size. For this reason, the D2O peak can be considered 
an HDO peak because pure deuterium oxide would not appear on the spectra. 
 
Figure 3.1 – NorCMC Synthesis Scheme: The synthetic scheme for the synthesis of NorCMC. 
 
Inaccurate masses of NorCMC alter the NorCMC wt% and T:Nb of hydrogels. If CNF is 
incorporated, inaccurate amounts of NorCMC also change the total wt% and CNF % of the 
hydrogels. For these reasons, having completely pure NorCMC is imperative. The analyses of the 
various batches of NorCMC showed that on average, NorCMC was anywhere from 18-22% 
functionalized. The CMC is approximately 70% functionalized, meaning that 70% of the 
anhydroglucose repeat units contain carboxymethyl groups. NorCMC that is approximately 20% 
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functionalized means that approximately 20% of those carboxymethyl groups had been 
functionalized with norbornene groups via amide linkages. 
 
Figure 3.2 – NorCMC Batch 1 1H NMR Spectrum: The 1H NMR spectrum of NorCMC batch 1 
showing the integrations corresponding with the alkene (Ha) and bridge (Hb) protons and the 
CMC protons. 
 
 
3.2 Hydrogel Swelling Studies 
 
Swelling studies were used to examine the hydrogel network behavior within solvents. 
When PBS is added to the wells, it immediately diffuses into the hydrogels because its driving 
force, osmotic pressure, is to dilute the polymers. Conversely, there is an elastic component of the 
hydrogels that resists swelling due to the chains being unable to move freely. These two forces – 
osmotic pressure and elastic resistance – work against each other; eventually, once swelling 
equilibrium is reached, a balance between the osmotic pressure and elastic resistance will occur. 
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More specifically, at swelling equilibrium water’s chemical potential inside the hydrogel networks 
is equal to its chemical potential outside. 
Before any CNF was added, hydrogels made using only NorCMC at various wt%s (Figure 
3.3) to establish a baseline for swelling using only one polymer in the system. Hydrogels made 
using a T:Nb = 0.25 exhibited average swelling percentages anywhere between approximately 
150-200%, while hydrogels made using a T:Nb = 1 showed average swelling percentages of 
approximately -18-10%. The larger average swelling percentages of the T:Nb = 0.25 hydrogels 
showed that these hydrogels exhibited less elastic resistance in comparison to the T:Nb = 1 
hydrogels. The lower elastic resistance of the T:Nb = 0.25 hydrogels can be attributed to their 
reduction of crosslinks. Conversely, because the T:Nb = 1 hydrogels exhibited negative average 
swelling percentages, it is shown that these networks had more powerful elastic resistance, thus 
overriding any swelling from osmotic pressure. 
 
Figure 3.3 – Swelling Data from 0% CNF Hydrogels: The average swelling percentages of 
hydrogels made without CNF, varying NorCMC wt%. The error bars represent one standard 
deviation (n≥5). 
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When considering Figure 3.3, regardless of the total wt%, all NorCMC hydrogels showed 
a decrease in average swelling percentage corresponding to an increase in T:Nb. This trend is due 
to the increased elastic resistance that is added to the hydrogel networks from the additional 
crosslinks formed as the T:Nb is increased. At higher T:Nbs, the hydrogels have more crosslinkers 
available, and therefore more chemical crosslinks are created. When comparing hydrogels made 
with the same wt% but different T:Nb, the osmotic pressure driving the swelling remains the same 
within all hydrogels, regardless of their T:Nb, because they contain the same amount of NorCMC. 
However, increasing the T:Nb increases the elastic resistance of the hydrogels, and consequently 
results a less swollen equilibrium (Figure 3.4). 
 
Figure 3.4 – Hydrogel Swelling at Various T:Nbs: A schematic representation of hydrogel 
networks containing the same amount of NorCMC but varying the amounts of chemical 
crosslinks and their subsequent swelling. 
 
Another trend observed was that regardless of the total wt%, the hydrogels made with the 
same T:Nbs swelled similar amounts. While there is more material within the hydrogels made 
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using higher wt%s, there are also more crosslinks within those networks. Because there is more 
NorCMC present in hydrogels made using higher wt%s, the osmotic pressure increases, and more 
water can diffuse in. However, hydrogels made using higher wt%s also contain more crosslinks, 
in turn increasing their elastic resistance and making them better equipped to combat swelling. As 
a result of the increased osmotic pressure and elastic resistance, hydrogels made with the same 
T:Nb, but different total wt%s exhibit similar swelling behavior (Figure 3.5). 
 
Figure 3.5 – Hydrogel Swelling at Various NorCMC wt%s: A schematic representation of 
hydrogel networks containing the same T:Nb, but different amounts of NorCMC, and their 
subsequent swelling. 
 
The addition of CNF into hydrogel networks has been shown to decrease the average 
swelling percentages (Figures 3.6-8). This can be explained by examining the NorCMC and CNF 
polymers. To start, NorCMC polymer chains exhibit carboxylic acid functional groups on some 
chains, and many hydroxyl groups within the backbone. The combination of these two functional 
groups makes these polymer chains more hydrophilic and available to interact with water. On the 
other hand, CNF has fewer hydroxyl groups available for hydrogen bonding within solvent 
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because on a mass basis, CNFs are much larger than CMC chains. Because CNF is composed of 
a collection of fibers, the hydroxyl groups on these fibers often tend to overlap and interact with 
themselves, forming areas where the polymer is not as available to interact with solvents. 
 
Figure 3.6 – Swelling Data from 2 wt% Total Hydrogels: A comparison of the swelling data 
from the 2 wt% total hydrogels. The error bars represent one standard deviation (n≥5). 
 
 
Figure 3.7 – Swelling Data from 3 wt% Total Hydrogels: A comparison of the swelling data 
from the 3 wt% total hydrogels. The error bars represent one standard deviation (n≥5). 
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Figure 3.8 – Swelling Data from 4 wt% Total Hydrogels: A comparison of the swelling data 
from the 4 wt% total hydrogels. The error bars represent one standard deviation (n≥5). 
 
The results of Figures 3.6-8 show that the addition of CNF decreases swelling. The 
swelling decrease associated with the addition of CNF can be attributed to two things: CNF’s lower 
affinity for water and the increased elastic resistance provided by CNF. Swelling equilibrium 
varies for each hydrogel network, and networks made with only NorCMC have increased osmotic 
pressure due to NorCMC’s affinity for water. Consequently, the use of CNF instead of NorCMC 
decreases osmotic pressure. Additionally, CNF adds effective crosslinks via entanglement of 
chains, thus increasing the elastic resistance within hydrogels. The combination of decreased 
osmotic pressure and increased elastic resistance within these hydrogels results in lower average 
swelling percentages (Table 3.1). 
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Table 3.1 – Summary of Average Swelling Percentages: A comparison summary of the average 
swelling percentages of the hydrogels made using the standard T:Nbs (0.25, 0.5, 0.75, 1) and 
varying total wt%s and CNF %s. 
Total wt% T:Nb 0% CNF 10% CNF 30% CNF 50% CNF 
2 
0.25 190±20 140±40 N/A N/A 
0.5 40±5 40±7 40±20 30±20 
0.75 0±4 6±10 3±4 -2±3 
1 -20±3 -20±5 -9±7 -4±3 
3 
0.25 190±50 100±20 50±9 9±9 
0.5 60±5 40±10 20±2 20±4 
0.75 20±4 10±7 5±2 5±4 
1 -8±2 -9±6 -9±2 6±4 
4 
0.25 200±10 100±10 50±2 10±7 
0.5 70±4 40±5 30±2 20±4 
0.75 30±4 20±1 20±2 10±6 
1 9±6 1±3 -1±3 2±10 
 
 
3.3 Measuring Hydrogel Moduli by Compression Testing 
 
A hydrogel’s function and therefore potential applicative areas rely immensely on the 
hydrogel’s modulus. As a result, the ability to finetune hydrogels and develop materials that exhibit 
the desired moduli is crucial for the success and viability of various applications. Compression 
testing was performed to determine the moduli of various hydrogels made using an assortment of 
T:Nbs, NorCMC and CNF concentrations, and total wt%s. Each formulation yielded hydrogels 
that possessed different network structures; however, while some networks proved to behave very 
similarly, others varied drastically. Regardless of the similarities or differences, the analysis of the 
compression moduli of these networks gave invaluable information about each individual network, 
trends seen amongst the networks, and how to design hydrogels for various applications. 
Much like how crosslinks improve a hydrogel’s ability to retain its shape, this same 
principle contributes to the hydrogels in terms of compression testing. As a force is applied to the 
hydrogels, they deform to various degrees depending on their crosslinks (Figure 3.9). This means 
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that because crosslinks can be thought of as junctions that strengthen the chains within networks 
by tethering them together, hydrogels containing more crosslinks can better combat forces applied 
to them. Conversely, hydrogels lacking crosslinks may experience distortion and chain collapse. 
Furthermore, a compression modulus is essentially a measure of a hydrogel’s resistance to 
deformation; more specifically in this case, a hydrogel’s resistance to a normal force exerted by a 
fixture. In short, hydrogels containing more crosslinks will deform to a lesser extent than those 
containing comparatively fewer crosslinks, and as a result will exhibit higher compression moduli. 
 
Figure 3.9 – Hydrogel Deformation Upon Compression: A schematic representation and 
comparison of how the relative number of crosslinks within a hydrogel determines its 
deformation when force is applied. 
 
After reaching swelling equilibrium, the 0% CNF hydrogels were used for compression 
testing to determine a baseline for hydrogels made without CNF. Without CNF, these moduli of 
these hydrogels would be based on chemical crosslinks only. The first trend observed was an 
increase in average compression moduli as the T:Nb increased (Figure 3.10). This trend was 
observed amongst all the total wt%s, showing that the addition of crosslinker added elastic 
resistance. This extra elastic resistance allowed the hydrogels to exhibit higher compression 
moduli. 
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Figure 3.10 – Compression Data from 0% CNF Hydogels: The average compression moduli of 
hydrogels made without CNF, varying total wt%. The error bars represent one standard deviation 
(n≥5). 
 
In addition to the comparison of the data within their own wt%s, comparisons could also 
be made between the sets of differing wt%s. When considering theoretical numbers of effective 
crosslinks created within the hydrogels, it follows that hydrogels made with lower wt%s would 
require higher T:Nbs to reach the same or similar numbers of effective crosslinks that higher wt% 
hydrogels would contain. More specifically, in order to contain the same number of effective 
crosslinks as a 4 wt% total hydrogel made with a T:Nb of 0.5, a 2 wt% total hydrogel would have 
to be made with a T:Nb of 1 (Figure 3.11). When these data were compared (Figure 3.10), it was 
found that both data sets exhibited average compression moduli of approximately 20 kPa, thus 
confirming that the experimental data followed theory. 
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Figure 3.11 – Comparison of Thiol:Norbornene: A schematic of a 2 wt% total, T:Nb = 1 (left) or 
4 wt% total, T:Nb = 0.5 (right) hydrogel, showing the similarities in number of effective 
crosslinks, but differences in total wt% and T:Nb. 
 
The average compression moduli changed significantly as CNF was incorporated into the 
hydrogel networks. The addition of CNF introduced physical crosslinks, which created systems 
containing two types of crosslinks. Unlike chemical crosslinks, physical crosslinks are not 
chemically linked to any part of the hydrogels; instead they are entangled within the NorCMC 
chains and provide support through entanglement. While the addition physical crosslinks added 
effective crosslinks to the system, it came with a penalty. Because the total wt% was kept at a 
consistent 2, 3, or 4 wt%, the introduction of CNF in turn decreased the NorCMC wt%. Meaning 
that a 2 wt% total hydrogel made with 50% CNF contained only 1 wt% NorCMC because the other 
1 wt% was composed of CNF (Figure 3.12). So, while the new physical crosslinks contributed 
effective crosslinks to the network, there were fewer chemical crosslinks made due to the 
decreased availability of the NorCMC. 
 
Figure 3.12 – Comparison of NorCMC wt%s: A schematic showing the difference in NorCMC 
content, and therefore chemical crosslinks, within 0% CNF (left) or 50% CNF (right) hydrogels. 
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Hydrogels made using 10% CNF (Figure 3.13) were compared to those made using 0% 
(Figure 3.10). The trends observed were similar to those of the 0% CNF, showing an increase in 
average compression moduli as the T:Nb or total wt% increased. However, all average 
compression moduli had increased by a significant amount. When considering Figures 3.10 and 
3.13, the hydrogel formulation with the lowest average compression modulus of approximately 1 
kPa was composed of 2 wt% total, T:Nb = 0.25, and 0% CNF. When the amount of CNF within 
this hydrogel formulation was increased, making a 2 wt% total, T:Nb = 0.25 hydrogel containing 
10% CNF, the average compression modulus was measured to be approximately 8 kPa. 
 
Figure 3.13 – Compression Data from 10% CNF Hydrogels: The average compression moduli of 
hydrogels made with 10% CNF. The error bars represent one standard deviation (n≥5). 
 
Further investigation of other hydrogels made using higher CNF %s revealed similar trends 
linking the addition of CNF to the increase of the average compression moduli. More specifically, 
hydrogels made using both 30% (Figure 3.14) and 50% CNF (Figure 3.15) exhibited significantly 
higher average compression moduli when compared to those made using 0 or 10% CNF. In both 
cases involving higher CNF %s, a clear divide between each wt% was observed. Furthermore, the 
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addition of CNF appeared to have even greater influence over the average compression moduli of 
hydrogels made with higher T:Nbs. This may have been due to the fact that an increased number 
of chemical crosslinks would better entrap the CNF within the networks, and potentially secure 
added support. 
 
Figure 3.14 – Compression Data from 30% CNF Hydrogels: The average compression moduli of 
hydrogels made with 30% CNF. The error bars represent one standard deviation (n≥5). 
 
 
Figure 3.15 – Compression Data from 50% CNF Hydrogels: The average compression moduli of 
hydrogels made with 50% CNF. The error bars represent one standard deviation (n≥5). 
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It also appeared that in terms of deformation resistance, the physical crosslinks from the 
CNF contributed more effective crosslinks than the chemical crosslinks from the NorCMC. This 
interpretation came from the fact that hydrogels made using 50% CNF exhibited significantly 
higher average compression moduli across the board when compared to their 0% CNF counterparts 
(Figure 3.16). The chemical crosslinks were assumed to be proportional to the concentration of 
DTT. If the number of effective crosslinks created using physical crosslinks was equal to the 
number created using chemical crosslinks, then in theory, the average compression moduli should 
be the same amongst hydrogels made using the same T:Nbs and total wt%s, regardless of the CNF 
%. However, the CNF hydrogels are shown to contain more effective crosslinks because they 
exhibit higher compression moduli. Additionally, the higher compression moduli may also be due 
to the fact that the CNF chains are more rigid than NorCMC chains. 
 
Figure 3.16 – Comparison of Compression Data from 0 and 50% CNF Hydrogels: A comparison 
of the compression moduli from hydrogels made using the same amount of DTT and either 0 or 
50% CNF with varying total wt%s, showing the effects of CNF on the average compression 
moduli. The error bars represent one standard deviation (n≥5). 
 
In addition to being grouped based on CNF % and compared between total wt%s, the 
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19). When considering the differences between certain sets of hydrogels, such as the 10 and 30% 
or the 30 and 50% CNF shown in Figure 3.17, the error bars imply that these values may not be 
significantly different at all. These similarities between the CNF %s were present within the data 
sets of the hydrogels made using a 3 wt% (Figure 3.18) and 4 wt% total (Figure 3.19). 
 
Figure 3.17 – Compression Data from 2 wt% Total Hydrogels: The compression data from the 
hydrogels made with a 2 wt% total. The error bars represent one standard deviation (n≥5). 
 
 
Figure 3.18 – Compression Data from 3 wt% Total Hydrogels: The compression data from the 
hydrogels made with a 3 wt% total. The error bars represent one standard deviation (n≥5). 
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Figure 3.19 – Compression Data from 4 wt% Total Hydrogels: The compression data from the 
hydrogels made with a 4 wt% total. The error bars represent one standard deviation (n≥5). 
 
At higher total wt%s, there appeared to be more remarkable differences between the 
hydrogels of each CNF %. These differences can be attributed to the formation of more effective 
crosslinks within the higher wt% hydrogels. Table 3.2 illustrates how the jump from each CNF % 
results in larger CNF wt% changes in the higher wt% hydrogels. For example, the CNF wt%s from 
10 and 30% of 2 wt% total are closer than those from the 10 and 30% of 4 wt% total (Table 3.2). 
Table 3.2 – NorCMC and CNF wt%s: A comparison of the NorCMC and CNF wt%s used. 
Total wt% % CNF NorCMC wt% CNF wt% 
2 
0 2 0 
12 1.8 0.2 
30 1.4 0.6 
50 1 1 
3 
0 3 0 
12 2.7 0.3 
30 2.1 0.9 
50 1.5 1.5 
4 
0 4 0 
12 3.6 0.4 
30 2.8 1.2 
50 2 2 
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Additionally, hydrogels made using the same total wt%s and CNF %s, but varying the 
T:Nbs exhibited compression moduli that were also not statistically different. While more 
prominent in the hydrogels made using higher CNF %s, this trend was observed in all of the 
hydrogels containing CNF. The consistent moduli associated with varying numbers of chemical 
crosslinks shows that there exists a critical concentration of effective crosslinks required for form 
hydrogel networks. Once this number is reached, the hydrogel systems behave similarly until the 
addition of CNF. Furthermore, these observations imply that the addition of CNF drastically 
increases the number of effective crosslinks within these systems. 
In a general summary, the average compression moduli of the hydrogels made using 
varying T:Nbs, total wt%s, and CNF %s span over a large range of values, dropping as low as 
approximately 1 kPa and rising as high as approximately 150 kPa (Table 3.3). This range not only 
demonstrates the effects that CNF can have on the strength of these hydrogel networks, but also 
illustrates the tunability of hydrogel modulus achieved through adjusting multiple variables in 
tandem with one another. 
Table 3.3 – Average Compression Moduli Comparison: A comparison summary of the average 
compression moduli of the hydrogels made using the standard T:Nbs (0.25, 0.5, 0.75, 1) and 
varying total wt%s and CNF %s. 
Total wt% T:Nb 0% CNF 10% CNF 30% CNF 50% CNF 
2 
0.25 1±1 8±4 N/A N/A 
0.5 5±1 20±9 20±10 20±10 
0.75 10±2 20±9 20±9 30±10 
1 20±2 20±3 20±9 30±6 
3 
0.25 N/A 10±2 30±8 4±2 
0.5 8±1 30±20 80±20 50±10 
0.75 20±3 40±10 70±20 80±20 
1 40±5 60±20 50±10 60±30 
4 
0.25 3±1 30±5 60±7 3±2 
0.5 20±1 80±30 110±20 110±20 
0.75 40±8 80±20 150±10 140±30 
1 70±10 100±10 110±20 150±30 
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Furthermore, the addition of CNF into hydrogel networks adds an extra layer of complexity 
because of the introduction of physical crosslinks and their subsequent altering of the network 
structure and behavior. CNF was shown to be an invaluable tool when it came to adding network 
support and increasing the average compression moduli without changing the total wt%s of the 
hydrogels. Remarkable increases in the average compression moduli of various hydrogels were 
observed when only small amounts of CNF were incorporated into their networks. The capabilities 
of these physical crosslinks included adding to the numbers of effective crosslinks within the 
hydrogels, but also showcased their ability to increase moduli after the critical number of chemical 
crosslinks had been reached. 
 
3.4 Discussion of Effective Crosslinks 
 
Chemical crosslinks are defined as chemical bonds between two norbornene groups, 
essentially linking the two together. Unfortunately, ineffective crosslinks, such as “loops,” and 
ineffective reactions, such as “dangling ends,” exist (Figure 3.20). Instead of connecting two 
norbornene groups from different chains, loops connect two norbornene active sites on the same 
chain. Because the chains are already held together by the cellulose backbone, these types of 
crosslinks are ultimately ineffective at tethering and maintaining the network during various 
external stimuli. When a crosslinker is connected to one norbornene but not a second, it is 
considered a dangling end. Dangling ends are the results of ineffective reactions and can neither 
help resist deformation when force is applied nor maintain the hydrogel structure and networks 
during swelling and degradation events. 
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Figure 3.20 – Ineffective Reactions and Crosslinks vs Effective Chemical Crosslinks: A 
schematic example and comparison of ineffective reactions (in the form of dangling ends) and 
crosslinks (in the form of loops) versus effective crosslinks. 
 
Similar to the ineffective chemical crosslinks, there exist ineffective physical crosslinks 
with hydrogel networks. The addition of CNF into these systems provides additional support for 
the networks in the form of physical crosslinks. While the entanglement of the CNF chains 
contributes to the physical crosslinks, dangling ends can still form and remain present. Much like 
the case of chemical crosslinks, these dangling ends add to the ineffective crosslinks within the 
hydrogel’s network. As a result, the combination of dangling ends and loops, derived from both 
NorCMC and CNF chains, contributes to the ineffective crosslinks within hydrogel networks. 
When considering the effect that the concentration of DTT will have on the hydrogel 
networks, theory would suggest that in a perfect system the concentration of DTT would be directly 
equal to the concentration of effective chemical crosslinks. Moreover, in a perfect system there is 
an assumption that dangling ends and loops do not exist; additionally, all DTT added to the system 
is assumed to react and form effective crosslinks. In the simplest case, hydrogel networks created 
with only NorCMC (Figure 3.21) were examined to determine how closely networks containing 
only chemical crosslinks followed theory. 
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Figure 3.21 – Average Effective Crosslinks from 0% CNF Hydrogels: The concentration of 
average effective crosslinks plotted against the concentration of DTT crosslinker used to make 
hydrogels with 0% CNF. The error bars represent one standard deviation (n≥5). 
 
The concentrations of average effective crosslinks were plotted against the concentrations 
of DTT crosslinker in order to examine and compare the experimental results to the expected 
theoretical trend (Figure 3.21). At lower DTT concentrations, the experimental values of the 0% 
CNF hydrogels followed theory. However, as the DTT concentrations increased, the experimental 
data began to deviate from theory, but continued with the expected upward trend. This deviation 
was observed amongst the higher wt% hydrogels, such as the 3 and 4 wt%, and may be explained 
by the fact that these hydrogels contain more material. While chemical crosslinks are the major 
focus when it comes to the analysis of NorCMC chains within these networks, the NorCMC chains 
are capable of entanglement, and therefore can create physical crosslinks. Therefore, the deviation 
of the experimental results from the expected theoretical values at higher wt%s can be explained 
by the additional crosslinks not accounted for by DTT concentration alone. Similarly, for the 
hydrogels containing CNF, Figures 3.22-24 illustrate that at low DTT concentrations, the number 
of effective crosslinks is essentially the same. 
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Figure 3.22 – Average Effective Crosslinks from 10% CNF Hydrogels: The concentration of 
average effective crosslinks plotted against the concentration of DTT crosslinker used to make 
hydrogels with 10% CNF. The error bars represent one standard deviation (n≥5). 
 
 
Figure 3.23 – Average Effective Crosslinks from 30% CNF Hydrogels: The concentration of 
average effective crosslinks plotted against the concentration of DTT crosslinker used to make 
hydrogels with 30% CNF. The error bars represent one standard deviation (n≥5). 
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Figure 3.24 – Average Effective Crosslinks from 50% CNF Hydrogels: The concentration of 
average effective crosslinks plotted against the concentration of DTT crosslinker used to make 
hydrogels with 50% CNF. The error bars represent one standard deviation (n≥5). 
 
The addition of CNF into the hydrogel systems revealed far more deviation from theory 
because of the significant number of physical crosslinks. As more CNF was introduced, more 
physical crosslinks were created, and the percentage of crosslinks formed using DTT decreased. 
As a result, the DTT concentration became only a portion of the effective crosslinks formed, and 
the effects of the physical crosslinks manifested in the effective crosslink calculations. 
The calculation of effective crosslinks takes all types of crosslinks (Figure 3.25) into 
account, while the concentration of DTT only accounts for the theoretical chemical crosslinks. 
Due to the larger number of physical crosslinks present in hydrogels made using higher CNF %s, 
there would be a larger discrepancy between the experimental and theoretical values. The 
experimental results of these calculations and the subsequent comparisons to theoretically 
calculated values not only confirm the expected addition of effective crosslinks that CNF was 
theorized to provide, but also show just how significant the physical crosslink contribution from 
CNF is. 
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Figure 3.25 – Chemical vs Physical Crosslinks: A schematic representation of the chemical and 
physical crosslinks within the networks containing NorCMC and CNF. 
 
In the context of the hydrogels created using varying percentages of CNF, there is a 
difference between whether the CNFs contribute as reinforcing agents or creating interpenetrating 
networks. At lower percentages, for example the 10% CNF hydrogels (Figure 3.22), the 
concentration of CNF within the hydrogels is so much smaller than the concentration of NorCMC 
that the CNFs contribute to the hydrogels as reinforcing agents. As a result, the 10% CNF 
hydrogels follow theory at lower DTT concentrations, only deviating at higher total wt%s where 
the concentration of CNF would be higher. Conversely, hydrogels containing larger percentages 
of CNF consist of interpenetrating networks. As shown in Figure 3.24, the number of effective 
crosslinks within 50% CNF hydrogels deviates significantly from the DTT concentration because 
CNF plays such a large role within the networks. 
 
3.5 Exploring Hydrogel Degradation 
 
Degradation is one of the key properties that make hydrogels desirable materials used for 
a multitude of applications. In order to better understand and control the degradation rates of 
various hydrogels, degradation studies were used to examine networks behavior over time.  
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3.5.1 Hydrogel Burst Releases 
 
Immediately following hydrogel synthesis, before any solvent addition, the networks 
contain bound materials, such as the newly crosslinked NorCMC and CNF chains, and unbound 
materials, such as unreacted crosslinker and reacted initiator fragments (Figure 3.26). Upon solvent 
addition, the unbound materials diffuse out of the networks in what is known as the burst release 
(Figure 3.27). This burst release, also known as the sol fraction of a hydrogel, gives information 
about the materials initially incorporated into the hydrogel networks. 
 
Figure 3.26 – Reagents Used to Create Hydrogels: A schematic showing the reagents used to 
create the hydrogels, and their roles, whether chemically bound or just spectators, within the 
hydrogel networks. 
 
 
Figure 3.27 – Hydrogel Burst Release: A schematic showing the diffusion of unbound materials 
out of the hydrogel networks over time. 
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The concentration of the unbound materials within the hydrogel networks plays a role in 
how quickly these materials diffuse out of the networks. Higher concentrations within the networks 
will lead to higher osmotic pressure, and therefore materials at higher internal concentrations 
within the networks will diffuse out faster. The affinity that certain reagents have for the 
components of the network versus the water from the PBS will also play a role in the rate at which 
diffusion outward happens. For example, if one type of small molecule is very attracted to the 
hydroxyl groups on the NorCMC backbone, these molecules may require more time to diffuse out 
of the networks. On the other hand, if a small molecule is particularly hydrophilic, it would have 
a greater affinity for the water, and therefore diffuse out of the network faster. 
For each total wt%, both NorCMC and CNF burst releases were quantified separately 
before being combined to illustrate burst release in terms of total polymeric losses. The NorCMC 
burst releases from the 2 wt% total hydrogels (Figure 3.28) were larger than those from 4 wt% 
total hydrogels (Figure 3.29). This was expected, because at higher wt%s, there would be more 
chemical crosslinks formed, and therefore more NorCMC would be incorporated into the hydrogel 
networks initially. Taking error bars into account, the burst releases within each CNF % appear to 
be static, thus implying that the maximum number of chemical crosslinks were formed at each 
T:Nb. During the synthesis of the 2 wt% total, 50% CNF hydrogels, it was discovered that 
hydrogels made using a T:Nb = 0.25 would not form. This inability to form can be attributed to 
the fact that there exists a minimum number of effective crosslinks required to create a hydrogel. 
Additionally, CNF may inhibit NorCMC chains from reaching each other, effectively reducing the 
number of chemical crosslinks that can be made. With a reduced number of chemical crosslinks, 
hydrogels made using these formulations cannot form (Figure 3.30). 
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Figure 3.28 – NorCMC Burst Releases from 2 wt% Total Hydrogels: The burst releases from the 
hydrogels made using a 2 wt% total. The error bars represent one standard deviation (n≥2). 
 
 
Figure 3.29 – NorCMC Burst Releases from 4 wt% Total Hydrogels: The burst releases from the 
hydrogels made using a 4 wt% total. The error bars represent one standard deviation (n=3). 
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Figure 3.30 – Hydrogel Mesh Sizes: A schematic showing an increase in mesh size as more CNF 
is added, replacing NorCMC, within hydrogel networks. 
 
Much like their NorCMC counterparts, the CNF burst releases from the 2 (Figure 3.31) 
and 4 wt% total hydrogels (Figure 3.32) showed a decrease in CNF losses associated with higher 
total wt%s and increased T:Nbs. Both observations can be explained by considering the mesh sizes 
within the corresponding hydrogels. More crosslinked hydrogels would contain smaller mesh 
sizes, and therefore exhibit lower CNF burst releases. 
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Figure 3.31 – CNF Burst Releases from 2 wt% Total Hydrogels: The CNF burst releases from 
the hydrogels made using a 2 wt% total. The error bars represent one standard deviation (n≥2). 
 
 
Figure 3.32 – CNF Burst Releases from 4 wt% Total Hydrogels: The CNF burst releases from 
the hydrogels made using a 4 wt% total. The error bars represent one standard deviation (n=3). 
 
 
Once combined into total burst releases, the NorCMC and CNF data from both the 2 
(Figure 3.33) and 4 wt% total hydrogels (Figure 3.34) revealed that NorCMC accounted for the 
primary losses in the 10 and 30% CNF cases. Conversely, in the 50% CNF cases, it was more 
even, with both NorCMC and CNF contributing to the burst releases. The 50% CNF hydrogels 
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exhibited significantly higher CNF burst releases when compared to their 10 and 30% CNF 
counterparts (Tables 3.4-5), because, with the least amount of NorCMC present, these hydrogels 
were unable to form the necessary number of effective crosslinks to incorporate all the CNF into 
the networks. It also follows that because the 50% CNF hydrogels contained the most CNF when 
compared to the 0, 10, and 30% hydrogels, it would be more likely that CNF would not be 
incorporated into the networks, and therefore be lost in the burst release. Additionally, the 
combined data show that regardless of the T:Nb, hydrogels made using 2 wt% total, 50% CNF lost 
roughly the same percentage of CNF during the burst release period (Table 3.4), implying that 
none of their mesh sizes were adequate for CNF retention. 
 
 
Figure 3.33 – Burst Release Polymeric Losses from 2 wt% Total Hydrogels: The calculated 
mass-based percentages of NorCMC and CNF lost from the 2 wt% total hydrogels after 24 
hours. The error bars represent one standard deviation (n≥2). 
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Table 3.4 – Calculated Burst Releases from 2 wt% Total Hydogels: The calculated mass-based 
percentages of NorCMC and CNF lost from the 2 wt% total hydrogels after 24 hours. 
% CNF Total wt% T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
10 
NorCMC 30±2 40±7 20±4 20±2 
CNF 4±1 3±3 1±0 0±0 
30 
NorCMC 70 30±2 10±2 20±4 
CNF 30 8±2 5±3 0±0 
50 
NorCMC N/A 30±4 30±4 10±3 
CNF N/A 20±1 20±1 10±3 
 
 
Figure 3.34 – Burst Release Polymeric Losses from 4 wt% Total Hydrogels: The calculated 
mass-based percentages of NorCMC and CNF lost from the 4 wt% total hydrogels made using 
various T:Nbs and CNF %s after 24 hours. The error bars represent one standard deviation (n=3). 
 
Table 3.5 – Calculated Burst Releases from 4 wt% Total Hydrogels: The calculated mass-based 
percentages of NorCMC and CNF lost from the 4 wt% total hydrogels after 28 days. 
% CNF Total wt% T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
10 
NorCMC 50±6 30±2 30±6 20±6 
CNF 3±1 1±0 1±0 0±0 
30 
NorCMC 40±1 30±1 20±4 20±6 
CNF 10±3 3±1 0±0 1±0 
50 
NorCMC 30±4 20±5 10±1 10±4 
CNF 20±4 10±1 6±1 1±1 
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3.5.2 Hydrogel Total Releases 
 
Following the initial burst release period, the amounts of NorCMC and CNF were 
quantified every week for a total of 28 days. The amounts of NorCMC and CNF lost between days 
7 to 28 can be considered products of network degradation because they represent the materials 
that were once incorporated into the hydrogels (Figure 3.35). Understanding NorCMC and CNF 
losses over time is imperative for describing the structure and stability of various networks. 
 
Figure 3.35 – Hydrogel Burst Release and Network Degradation: A schematic showing less 
crosslinked (top) vs more crosslinked (bottom) hydrogels and their losses at different time points. 
 
The total NorCMC losses associated with the 2 (Figure 3.36) and 4 wt% total hydrogels 
(Figure 3.37) revealed that in the majority of formulations, the hydrogels had lost their network 
structure and integrity by day 28. Some of the 4 wt% total hydrogels made with higher T:Nbs 
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remained intact by the end of the study due to their increased number of chemical crosslinks 
formed initially. 
 
Figure 3.36 – NorCMC Total Losses from 2 wt% Total Hydrogels: The total losses from the 
hydrogels made using a 2 wt% total. The error bars represent one standard deviation (n≥2). 
 
 
Figure 3.37 – NorCMC Total Losses from 4 wt% Total Hydrogels: The total losses from the 
hydrogels made using a 4 wt% total. The error bars represent one standard deviation (n=3). 
 
The total CNF losses associated with the 2 wt% total hydrogels (Figure 3.38) were 
significantly higher than those from the 4 wt% total hydrogels (Figure 3.39). Instead, the 4 wt% 
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total hydrogels made using T:Nb = 1 exhibited little to no CNF losses overall (Figure 3.39). The 
differences here may be attributed to the presence of more NorCMC, and therefore more chemical 
crosslinks, present in the 4 wt% total hydrogels. Moreover, the mesh sizes are expected to be 
smaller with the increase of either T:Nb or total wt%. 
 
Figure 3.38 – CNF Total Losses from 2 wt% Total Hydrogels: The total losses from the 
hydrogels made using a 2 wt% total. The error bars represent one standard deviation (n≥2). 
 
 
Figure 3.39 – CNF Total Losses from 4 wt% Total Hydrogels: The total losses from the 
hydrogels made using a 4 wt% total. The error bars represent one standard deviation (n=3). 
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Once combined into total overall losses, the NorCMC and CNF data from both the 2 
(Figure 3.40) and 4 wt% total hydrogels (Figure 3.41) revealed that in all cases except for the 50% 
CNF hydrogels, the majority of the losses were NorCMC. This implies that despite hydrolysis 
breaking some chemical crosslinks, the mesh sizes were not altered to a point where CNF could 
escape (Tables 3.6-7). Conversely, the mesh sizes in the 50% CNF hydrogels were altered by the 
chemical crosslink removal; these hydrogels subsequently exhibited significantly higher CNF 
losses, with the 2 wt% total hydrogels losing all their CNF by the end (Table 3.6). 
 
Figure 3.40 – Total Polymeric Losses from 2 wt% Total Hydrogels: The calculated mass-based 
percentages of NorCMC and CNF lost from the 2 wt% total hydrogels made using various T:Nbs 
and CNF %s after 28 days. The error bars represent one standard deviation (n≥2). 
 
Table 3.6 – Calculated Total Losses from 2 wt% Total Hydrogels: The calculated mass-based 
percentages of NorCMC and CNF lost from the 2 wt% total hydrogels after 28 days. 
% CNF Total wt% T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
10 
NorCMC 90 80±9 60±10 70±7 
CNF 10 4±3 1±1 1±0 
30 
NorCMC 70 60±10 50±10 50±20 
CNF 30 20±2 10±9 1±1 
50 
NorCMC N/A 50±2 30±4 10±1 
CNF N/A 50 50 50 
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Figure 3.41 – Total Polymeric Losses from 4 wt% Total Hydrogels: The calculated mass-based 
percentages of NorCMC and CNF lost from the 4 wt% total hydrogels made using various T:Nbs 
and CNF %s after 28 days. The error bars represent one standard deviation (n=3). 
 
Table 3.7 – Calculated Total Losses from 4 wt% Total Hydrogels: The calculated mass-based 
percentages of NorCMC and CNF lost from the 4 wt% total hydrogels after 28 days. 
% CNF Total wt% T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
10 
NorCMC 80±6 50±3 30±10 30±10 
CNF 5±0 1±0 2±1 0±0 
30 
NorCMC 60±2 50±3 40±7 50±3 
CNF 20±1 4±2 0±0 1±0 
50 
NorCMC 50±5 30±5 20±2 20±3 
CNF 40±9 20±3 7±1 2±2 
 
3.6 Targeting 10 and 100 kPa Moduli Hydrogels 
 
Once the hydrogels made using the standard total wt%s, T:Nbs, and CNF %s had 
undergone swelling, compression, and degradation studies, an effort was made to determine the 
formulations required to create 10 and 100 kPa moduli hydrogels with each CNF % (Figure 3.42). 
These moduli were chosen because they were an order of magnitude apart and represent the moduli 
of relevant tissues. Then, using the hydrogels with consistent moduli but varying CNF %s. It 
follows that lower total wt% hydrogels would contain fewer effective crosslinks, making them 
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better suited to provide hydrogels with moduli around 10 kPa. Conversely, hydrogels made with 
higher total wt%s gave moduli closer to 100 kPa (Table 3.8). 
 
Figure 3.42 – Summary 10 and 100 kPa Moduli Hydrogels: A summary of the hydrogel moduli 
(either 10 or 100 kPa) corresponding with hydrogels made using 0-50% CNF. The error bars 
represent one standard deviation (n≥5). 
 
Table 3.8 – Summary of 10 and 100 kPa Hydrogel Formulations: A summary of the formulations 
used to create 10 and 100 kPa moduli hydrogels with varying CNF %s. 
% CNF Modulus (kPa) Total wt% T:Nb 
0 
10 2 0.75 
100 5 0.75 
10 
10 3 0.25 
100 4 1 
30 
10 2 0.4 
100 4 0.5 
50 
10 2 0.45 
100 4 0.45 
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CHAPTER 4 
Chapter 4. Conclusions and Future Work 
CONCLUSIONS AND FUTURE WORK 
 
4.1 Conclusions 
 
The double network hydrogels composed of NorCMC and CNF have demonstrated 
tunability when it comes to desirable properties such as swelling, moduli, and degradation. 
Synthesis of these hydrogels was relatively straightforward to the point where cells could easily 
be encapsulated into them, making these hydrogels desirable for numerous biomedical 
applications. NorCMC was utilized for its norbornene groups, which readily reacted with dithiols 
to create chemical crosslinks. 
When examining the hydrogels formed using combinations of NorCMC and CNF, a critical 
number of effective crosslinks required to form hydrogels was discovered. This requirement 
revealed that some hydrogel formulations were simply not viable options for hydrogel formation 
and subsequent cell encapsulation. Furthermore, the addition of CNF added physical crosslinks to 
systems that were otherwise composed of predominantly chemical crosslinks. As a result, when 
the critical number of effective crosslinks was reached, CNF improved mechanical strength and 
slowed degradation rates associated with these hydrogels. 
Hydrogels were successfully made to exhibit moduli of 10 or 100 kPa, while containing 0, 
10, 30, or 50% CNF. This demonstrated a high degree of control over hydrogel properties because 
a constant modulus could be chosen, and hydrogels could be fine-tuned to contain a desired 
percentage of CNF. At low %s, CNF functioned as a reinforcing agent, adding support to the 
hydrogel networks. At higher %s, CNF and NorCMC worked in tandem to create IPNs with 
significantly more elastic resistance than their NorCMC only counterparts. Understanding how 
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these double network hydrogels function is a key step in the process of creating and designing new 
materials. 
 
4.2 Future Work 
 
Using the hydrogel formulations determined, hMSCs can be encapsulated inside these 
hydrogels and their growth and differentiation studied. The cell growth and differentiation can be 
further studied by functionalizing the NorCMC of these hydrogels with various small molecules, 
such as glycans. In addition to studying their effects on encapsulated cells, future studies to 
determine the effects on swelling, modulus, and degradation of these glycan functionalized 
hydrogels may be used. 
Utilizing CNF also expands the potential exploration of these double network hydrogels. 
CNF may be functionalized using a variety of materials and then used within hydrogels. NorCMC 
hydrogels made using functionalized CNF would have the potential to alter cell fate. Additionally, 
CNF can also be fluorescently tagged, opening new possibilities when it comes to quantification 
and future applications. 
Outside of the biomedical applications, because the addition of these CNF adds significant 
elastic resistance to hydrogels, materials exhibiting superelastic properties may be synthesized and 
studied. Autogelation, the process of creating hydrogels without the use of initiators, may also be 
explored using systems containing NorCMC and CNF. In short, using the knowledge gained from 
this research, new materials may be designed and synthesized with more control, thus opening 
endless potential applications. 
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APPENDICES 
 
A. Supplementary Data for Chapter 3 
 
A.1 1H NMR Spectra 
 
 
Figure A.1 – Hydrogel NMR: The 1H NMR spectrum of a hydrogel made with a T:Nb = 0.35 
and irradiated for 60 seconds. 
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Figure A.2 – Hydrogel NMR: The 1H NMR spectrum of a hydrogel made with a T:Nb = 0.7 and 
irradiated for 60 seconds. 
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Figure A.3 – Hydrogel NMR: The 1H NMR spectrum of a hydrogel made with a T:Nb = 1.05 
and irradiated for 60 seconds. 
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Figure A.4 – Hydrogel NMR: The 1H NMR spectrum of a hydrogel made with a T:Nb = 1.4 and 
irradiated for 60 seconds. 
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Figure A.5 – Hydrogel NMR: The 1H NMR spectrum of a hydrogel made with a T:Nb = 1.4 and 
irradiated for 15 seconds. 
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Figure A.6 – Hydrogel NMR: The 1H NMR spectrum of a hydrogel made with a T:Nb = 1.4 and 
irradiated for 30 seconds. 
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Figure A.7 – Hydrogel NMR: The 1H NMR spectrum of a hydrogel made with a T:Nb = 1.4 and 
irradiated for 120 seconds. 
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A.2 Swelling Data 
 
Table A.1 – Swelling Data from 2 wt% Total, 0% CNF Hydrogels: The average swelling 
percentages and standard deviations of the 2 wt% total, 0% CNF hydrogels. 
 Thiol:Norbornene Average Swelling Percentage (%)  
 0.25 190±20  
 0.5 40±5  
 0.75 0±4  
 1 -20±3  
 
 
Figure A.8 – Swelling Data from 2 wt% Total, 0% CNF Hydrogels: The swelling data from the 2 
wt% total, 0% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
 
Table A.2 – Swelling Data from 2 wt% Total, 10% CNF Hydrogels: The average swelling 
percentages and standard deviations of the 2 wt% total, 10% CNF hydrogels. 
 Thiol:Norbornene Average Swelling Percentage (%)  
 0.25 140±40  
 0.5 40±7  
 0.75 6±10  
 1 -20±5  
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Figure A.9 – Swelling Data from 2 wt% Total, 10% CNF Hydrogels: The swelling data from the 
2 wt% total, 10% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
 
Table A.3 – Swelling Data from 2 wt% Total, 30% CNF Hydrogels: The average swelling 
percentages and standard deviations of the 2 wt% total, 30% CNF hydrogels. 
 Thiol:Norbornene Average Swelling Percentage (%)  
 0.25 N/A  
 0.3 90±20  
 0.35 120±20  
 0.4 50±20  
 0.5 40±20  
 0.6 20±2  
 0.75 3±4  
 1 -9±7  
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Figure A.10 – Swelling Data from 2 wt% Total, 30% CNF Hydrogels: The swelling data from 
the 2 wt% total, 30% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
 
Table A.4 – Swelling Data from 2 wt% Total, 50% CNF Hydrogels: The average swelling 
percentages and standard deviations of the 2 wt% total, 50% CNF hydrogels. 
 Thiol:Norbornene Average Swelling Percentage (%)  
 0.25 N/A  
 0.4 30±10  
 0.45 50±10  
 0.5 30±20  
 0.6 20±9  
 0.75 -2±3  
 1 -4±3  
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Figure A.11 – Swelling Data from 2 wt% Total, 50% CNF Hydrogels: The swelling data from 
the 2 wt% total, 50% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
 
 
Figure A.12 – Swelling Data from 2 wt% Total Hydrogels: The combined swelling data from the 
hydrogels made using a 2 wt% total. The error bars represent one standard deviation (n≥5). 
 
Table A.5 – Swelling Data from 3 wt% Total, 0% CNF Hydrogels: The average swelling 
percentages and standard deviations of the 3 wt% total, 0% CNF hydrogels. 
 Thiol:Norbornene Average Swelling Percentage (%)  
 0.25 190±50  
 0.5 60±5  
 0.75 20±4  
 1 -8±2  
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Figure A.13 – Swelling Data from 3 wt% Total, 0% CNF Hydrogels: The swelling data from the 
3 wt% total, 0% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
 
Table A.6 – Swelling Data from 3 wt% Total, 10% CNF Hydrogels: The average swelling 
percentages and standard deviations of the 3 wt% total, 10% CNF hydrogels. 
 Thiol:Norbornene Average Swelling Percentage (%)  
 0.25 100±20  
 0.5 40±10  
 0.75 10±7  
 1 -9±6  
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Figure A.14 – Swelling Data from 3 wt% Total, 10% CNF Hydrogels: The swelling data from 
the 3 wt% total, 10% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
 
Table A.7 – Swelling Data from 3 wt% Total, 30% CNF Hydrogels: The average swelling 
percentages and standard deviations of the 3 wt% total, 30% CNF hydrogels. 
 Thiol:Norbornene Average Swelling Percentage (%)  
 0.25 50±9  
 0.5 20±2  
 0.75 5±2  
 1 -9±2  
 
 
Figure A.15 – Swelling Data from 3 wt% Total, 30% CNF Hydrogels: The swelling data from 
the 3 wt% total, 30% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
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Table A.8 – Swelling Data from 3 wt% Total, 50% CNF Hydrogels: The average swelling 
percentages and standard deviations of the 3 wt% total, 50% CNF hydrogels. 
 Thiol:Norbornene Average Swelling Percentage (%)  
 0.25 9±9  
 0.3 60±10  
 0.5 20±4  
 0.75 5±4  
 1 6±4  
 
 
 
Figure A.16 – Swelling Data from 3 wt% Total, 50% CNF Hydrogels: The swelling data from 
the 3 wt% total, 50% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
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Figure A.17 – Swelling Data from 3 wt% Total Hydrogels: The combined swelling data from the 
hydrogels made using a 3 wt% total. The error bars represent one standard deviation (n≥5). 
 
Table A.9 – Swelling Data from 4 wt% Total, 0% CNF Hydrogels: The average swelling 
percentages and standard deviations of the 4 wt% total, 0% CNF hydrogels. 
 Thiol:Norbornene Average Swelling Percentage (%)  
 0.25 200±10  
 0.5 70±4  
 0.75 30±4  
 1 9±6  
 
 
Figure A.18 – Swelling Data from 4 wt% Total, 0% CNF Hydrogels: The swelling data from the 
4 wt% total, 0% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
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Table A.10 – Swelling Data from 4 wt% Total, 10% CNF Hydrogels: The average swelling 
percentages and standard deviations of the 4 wt% total, 10% CNF hydrogels. 
 Thiol:Norbornene Average Swelling Percentage (%)  
 0.25 100±10  
 0.5 40±5  
 0.75 20±1  
 1 1±3  
 
 
Figure A.19 – Swelling Data from 4 wt% Total, 10% CNF Hydrogels: The swelling data from 
the 4 wt% total, 10% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
 
Table A.11 – Swelling Data from 4 wt% Total, 30% CNF Hydrogels: The average swelling 
percentages and standard deviations of the 4 wt% total, 30% CNF hydrogels. 
 Thiol:Norbornene Average Swelling Percentage (%)  
 0.25 50±2  
 0.35 30±5  
 0.4 30±2  
 0.5 30±2  
 0.75 20±2  
 1 -1±3  
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Figure A.20 – Swelling Data from 4 wt% Total, 30% CNF Hydrogels: The swelling data from 
the 4 wt% total, 30% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
 
Table A.12 – Swelling Data from 4 wt% Total, 50% CNF Hydrogels: The average swelling 
percentages and standard deviations of the 4 wt% total, 50% CNF hydrogels. 
 Thiol:Norbornene Average Swelling Percentage (%)  
 0.25 10±7  
 0.3 50±3  
 0.4 30±3  
 0.45 30±6  
 0.5 20±4  
 0.75 10±6  
 1 2±10  
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Figure A.21 – Swelling Data from 4 wt% Total, 50% CNF Hydrogels: The swelling data from 
the 4 wt% total, 50% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
 
 
Figure A.22 – Swelling Data from 4 wt% Total Hydrogels: The combined swelling data from the 
hydrogels made using a 4 wt% total. The error bars represent one standard deviation (n≥5). 
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Table A.13 – Summary of All Swelling Data: A comparison of the average swelling percentages 
of the hydrogels made using various total wt%s, T:Nbs, and CNF %s. 
Total wt% T:Nb 0% CNF 10% CNF 30% CNF 50% CNF 
2 
0.25 190±20 140±40 N/A N/A 
0.3 N/A N/A 90±20 N/A 
0.35 N/A N/A 120±20 N/A 
0.4 N/A N/A 50±20 30±10 
0.45 N/A N/A N/A 50±10 
0.5 40±5 40±7 40±20 30±20 
0.6 N/A N/A 20±2 20±9 
0.75 0±4 6±10 3±4 -2±3 
1 -20±3 -20±5 -9±7 -4±3 
3 
0.25 190±50 100±20 50±9 9±9 
0.3 N/A N/A N/A 60±10 
0.5 60±5 40±10 20±2 20±4 
0.75 20±4 10±7 5±2 5±4 
1 -8±2 -9±6 -9±2 6±4 
4 
0.25 200±10 100±10 50±2 10±7 
0.3 N/A N/A N/A 50±3 
0.35 N/A N/A 30±5 N/A 
0.4 N/A N/A 30±2 30±3 
0.45 N/A N/A N/A 30±6 
0.5 70±4 40±5 30±2 20±4 
0.75 30±4 20±1 20±2 10±6 
1 9±6 1±3 -1±3 2±10 
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A.3 Compression Data 
 
Table A.14 – Compression Data from 2 wt% Total, 0% CNF Hydrogels: The average 
compression moduli and standard deviations of the 2 wt% total, 0% CNF hydrogels. 
 Thiol:Norbornene Average Compression Modulus (kPa)  
 0.25 1±1  
 0.5 5±1  
 0.75 10±2  
 1 20±2  
 
 
Figure A.23 – Compression Data from 2 wt% Total, 0% CNF Hydrogels: The compression data 
from the 2 wt% total, 0% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
 
Table A.15 – Compression Data from 2 wt% Total, 10% CNF Hydrogels: The average 
compression moduli and standard deviations of the 2 wt% total, 10% CNF hydrogels. 
 Thiol:Norbornene Average Compression Modulus (kPa)  
 0.25 8±4  
 0.5 20±9  
 0.75 20±9  
 1 20±3  
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Figure A.24 – Compression Data from 2 wt% Total, 10% CNF Hydrogels: The compression data 
from the 2 wt% total, 10% CNF hydrogels. The error bars represent one standard deviation 
(n≥5). 
 
Table A.16 – Compression Data from 2 wt% Total, 30% CNF Hydrogels: The average 
compression moduli and standard deviations of the 2 wt% total, 30% CNF hydrogels. 
 Thiol:Norbornene Average Compression Modulus (kPa)  
 0.25 N/A  
 0.3 N/A  
 0.35 4±1  
 0.4 10±6  
 0.5 20±10  
 0.6 30±8  
 0.75 20±9  
 1 20±9  
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Figure A.25 – Compression Data from 2 wt% Total, 30% CNF Hydrogels: The compression data 
from the 2 wt% total, 30% CNF hydrogels. The error bars represent one standard deviation 
(n≥5). 
 
Table A.17 – Compression Data from 2 wt% Total, 50% CNF Hydrogels: The average 
compression moduli and standard deviations of the 2 wt% total, 50% CNF hydrogels. 
 Thiol:Norbornene Average Compression Modulus (kPa)  
 0.25 N/A  
 0.4 1±1  
 0.45 10±3  
 0.5 20±10  
 0.6 30±10  
 0.75 30±10  
 1 30±6  
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Figure A.26 – Compression Data from 2 wt% Total, 50% CNF Hydrogels: The compression data 
from the 2 wt% total, 50% CNF hydrogels. The error bars represent one standard deviation 
(n≥5). 
 
 
Figure A.27 – Compression Data from 2 wt% Total Hydrogels: The combined compression data 
from the hydrogels made using a 2 wt% total. The error bars represent one standard deviation 
(n≥5). 
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Table A.18 – Compression Data from 3 wt% Total, 0% CNF Hydrogels: The average 
compression moduli and standard deviations of the 3 wt% total, 0% CNF hydrogels. 
 Thiol:Norbornene Average Compression Modulus (kPa)  
 0.25 N/A  
 0.5 8±1  
 0.75 20±3  
 1 40±5  
 
 
Figure A.28 – Compression Data from 3 wt% Total, 0% CNF Hydogels: The compression data 
from the 3 wt% total, 0% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
 
Table A.19 – Compression Data from 3 wt% Total, 10% CNF Hydrogels: The average 
compression moduli and standard deviations of the 3 wt% total, 10% CNF hydrogels. 
 Thiol:Norbornene Average Compression Modulus (kPa)  
 0.25 10±2  
 0.5 30±20  
 0.75 40±10  
 1 60±20  
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Figure A.29 – Compression Data from 3 wt% Total, 10% CNF Hydogels: The compression data 
from the 3 wt% total, 10% CNF hydrogels. The error bars represent one standard deviation 
(n≥5). 
 
Table A.20 – Compression Data from 3 wt% Total, 30% CNF Hydrogels: The average 
compression moduli and standard deviations of the 3 wt% total, 30% CNF hydrogels. 
 Thiol:Norbornene Average Compression Modulus (kPa)  
 0.25 30±8  
 0.5 80±20  
 0.75 70±20  
 1 50±10  
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Figure A.30 – Compression Data from 3 wt% Total, 30% CNF Hydrogels: The compression data 
from the 3 wt% total, 30% CNF hydrogels. The error bars represent one standard deviation 
(n≥5). 
 
Table A.21 – Compression Data from 3 wt% Total, 50% CNF Hydrogels: The average 
compression moduli and standard deviations of the 3 wt% total, 50% CNF hydrogels. 
 Thiol:Norbornene Average Compression Modulus (kPa)  
 0.25 4±2  
 0.3 N/A  
 0.5 50±10  
 0.75 80±20  
 1 60±30  
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Figure A.31 – Compression Data from 3 wt% Total, 50% CNF Hydrogels: The compression data 
from the 3 wt% total, 50% CNF hydrogels. The error bars represent one standard deviation 
(n≥5). 
 
 
Figure A.32 – Compression Data from 3 wt% Total Hydrogels: The combined compression data 
from the hydrogels made using a 3 wt% total. The error bars represent one standard deviation 
(n≥5). 
 
 
 
 
 
0
20
40
60
80
100
120
0 0.25 0.5 0.75 1 1.25
A
ve
ra
ge
 C
o
m
p
re
ss
io
n
 M
o
d
u
lu
s 
(k
P
a)
Thiol:Norbornene
0
20
40
60
80
100
120
0 0.25 0.5 0.75 1 1.25
A
ve
ra
ge
 C
o
m
p
re
ss
io
n
 M
o
d
u
lu
s 
(k
P
a)
Thiol:Norbornene
0% CNF
10% CNF
30% CNF
50% CNF
129 
Table A.22 – Compression Data from 4 wt% Total, 0% CNF Hydrogels: The average 
compression moduli and standard deviations of the 4 wt% total, 0% CNF hydrogels. 
 Thiol:Norbornene Average Compression Modulus (kPa)  
 0.25 3±1  
 0.5 20±1  
 0.75 40±8  
 1 70±10  
 
 
 
Figure A.33 – Compression Data from 4 wt% Total, 0% CNF Hydrogels: The compression data 
from the 4 wt% total, 0% CNF hydrogels. The error bars represent one standard deviation (n≥5). 
 
Table A.23 – Compression Data from 4 wt% Total, 10% CNF Hydrogels: The average 
compression moduli and standard deviations of the 4 wt% total, 10% CNF hydrogels. 
 Thiol:Norbornene Average Compression Modulus (kPa)  
 0.25 30±5  
 0.5 80±30  
 0.75 80±20  
 1 100±10  
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Figure A.34 – Compression Data from 4 wt% Total, 10% CNF Hydrogels: The compression data 
from the 4 wt% total, 10% CNF hydrogels. The error bars represent one standard deviation 
(n≥5). 
 
Table A.34 – Compression Data from 4 wt% Total, 30% CNF Hydrogels: The average 
compression moduli and standard deviations of the 4 wt% total, 30% CNF hydrogels. 
 Thiol:Norbornene Average Compression Modulus (kPa)  
 0.25 60±7  
 0.35 80±20  
 0.4 110±20  
 0.5 110±20  
 0.75 150±10  
 1 110±20  
 
0
20
40
60
80
100
120
0 0.25 0.5 0.75 1 1.25
A
ve
ra
ge
 C
o
m
p
re
ss
io
n
 M
o
d
u
lu
s 
(k
P
a)
Thiol:Norbornene
131 
 
Figure A.35 – Compression Data from 4 wt% Total, 30% CNF Hydrogels: The compression data 
from the 4 wt% total, 30% CNF hydrogels. The error bars represent one standard deviation 
(n≥5). 
 
Table A.35 – Compression Data from 4 wt% Total, 50% CNF Hydrogels: The average 
compression moduli and standard deviations of the 4 wt% total, 50% CNF hydrogels. 
 Thiol:Norbornene Average Compression Modulus (kPa)  
 0.25 3±2  
 0.3 40±10  
 0.4 80±20  
 0.45 100±20  
 0.5 110±20  
 0.75 140±30  
 1 150±30  
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Figure A.36 – Compression Data from 4 wt% Total, 50% CNF Hydrogels: The compression data 
from the 4 wt% total, 50% CNF hydrogels. The error bars represent one standard deviation 
(n≥5). 
 
 
Figure A.37 – Compression Data from 4 wt% Total Hydrogels: The combined compression data 
from the hydrogels made using a 4 wt% total. The error bars represent one standard deviation 
(n≥5). 
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Table A.36 – Summary of All Compression Data: A summary of all of the compression data 
from the hydrogels made using varying total wt%s, T:Nbs, and CNF %s. 
Total wt% T:Nb 0% CNF 10% CNF 30% CNF 50% CNF 
2 
0.25 1±1 8±4 N/A N/A 
0.3 N/A N/A N/A N/A 
0.35 N/A N/A 4±1 N/A 
0.4 N/A N/A 10±6 1±1 
0.45 N/A N/A N/A 10±3 
0.5 5±1 20±9 20±10 20±10 
0.6 N/A N/A 30±8 30±10 
0.75 10±2 20±9 20±9 30±10 
1 20±2 20±3 20±9 30±6 
3 
0.25 N/A 10±2 30±8 4±2 
0.3 N/A N/A N/A N/A 
0.5 8±1 30±20 80±20 50±10 
0.75 20±3 40±10 70±20 80±20 
1 40±5 60±20 50±10 60±30 
4 
0.25 3±1 30±5 60±7 3±2 
0.3 N/A N/A N/A 40±10 
0.35 N/A N/A 80±20 N/A 
0.4 N/A N/A 110±20 80±20 
0.45 N/A N/A N/A 100±20 
0.5 20±1 80±30 110±20 110±20 
0.75 40±8 80±20 150±10 140±30 
1 70±10 100±10 110±20 150±30 
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A.4 Degradation Assay Data 
 
A.4.1 NorCMC Degradation Assay Data 
 
Table A.37 – NorCMC Degradation Data from 2 wt% Total, 0% CNF Hydrogels: The mass-
based percentage of NorCMC lost from the 2 wt% total, 0% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 0 0 0 0 
1 90±2 40±6 60±30 30±20 
7 90±2 70±10 70±20 40±30 
14 100±0 80±8 70±20 40±30 
21 100±1 90±3 80±20 50±40 
28 100 100 80±20 50±40 
 
 
Figure A.38 – NorCMC Degradation Data from 2 wt% Total, 0% CNF Hydrogels: The mass-
based percentage of NorCMC lost over time from the 2 wt% total, 0% CNF hydrogels. The error 
bars represent one standard deviation (n=3). 
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Table A.38 – NorCMC Degradation Data from 2 wt% Total, 10% CNF Hydrogels: The mass-
based percentage of NorCMC lost from the 2 wt% total, 10% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 0 0 0 0 
1 30±3 40±8 20±5 30±2 
7 70±20 50±3 40±20 40±10 
14 100 60±10 50±10 50±20 
21 100 70±10 60±9 70±6 
28 100 80±10 70±10 80±8 
 
 
Figure A.39 – NorCMC Degradation Data from 2 wt% Total, 10% CNF Hydrogels: The mass-
based percentage of NorCMC lost over time from the 2 wt% total, 10% CNF hydrogels. The 
error bars represent one standard deviation (n=3). 
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Table A.39 – NorCMC Degradation Data from 2 wt% Total, 30% CNF Hydrogels: The mass-
based percentage of NorCMC lost from the 2 wt% total, 30% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 0 0 0 0 
1 100 40±3 20±3 30±5 
7 100 60±1 30±3 40±9 
14 100 80±10 40±7 50±20 
21 100 80±10 50±9 60±20 
28 100 80±10 80±20 70±20 
 
 
Figure A.40 – NorCMC Degradation Data from 2 wt% Total, 30% CNF Hydrogels: The mass-
based percentage of NorCMC lost over time from the 2 wt% total, 30% CNF hydrogels. The 
error bars represent one standard deviation (n=3). 
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Table A.40 – NorCMC Degradation Data from 2 wt% Total, 50% CNF Hydrogels: The mass-
based percentage of NorCMC lost from the 2 wt% total, 50% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 
N/A 
0 0 0 
1 70±9 50±7 20±8 
7 90±5 60±5 20±8 
14 90±5 60±7 20±9 
21 90±4 60±7 20±9 
28 90±4 60±8 20±9 
 
 
Figure A.41 – NorCMC Degradation Data from 2 wt% Total, 50% CNF Hydrogels: The mass-
based percentage of NorCMC lost over time from the 2 wt% total, 50% CNF hydrogels. The 
error bars represent one standard deviation (n≥2). 
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Table A.41 – NorCMC Degradation Data from 4 wt% Total, 0% CNF Hydrogels: The mass-
based percentage of NorCMC lost from the 4 wt% total, 0% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 0 0 0 0 
1 50±20 50±7 40±30 30±6 
7 60±20 60±8 70±20 40±9 
14 80±10 60±8 70±20 40±20 
21 80±20 60±7 70±20 50±20 
28 100±6 60±5 80±20 50±20 
 
 
Figure A.42 – NorCMC Degradation Data from 4 wt% Total, 0% CNF Hydrogels: The mass-
based percentage of NorCMC lost over time from the 4 wt% total, 0% CNF hydrogels. The error 
bars represent one standard deviation (n=3). 
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Table A.42 – NorCMC Degradation Data from 4 wt% Total, 10% CNF Hydrogels: The mass-
based percentage of NorCMC lost from the 4 wt% total, 10% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 0 0 0 0 
1 60±3 40±8 30±7 20±4 
7 80±2 60±10 40±10 30±10 
14 90±1 60±10 40±10 30±10 
21 90±2 60±10 40±10 30±10 
28 90±2 60±10 40±10 30±10 
 
 
Figure A.43 – NorCMC Degradation Data from 4 wt% Total, 10% CNF Hydrogels: The mass-
based percentage of NorCMC lost over time from the 4 wt% total, 10% CNF hydrogels. The 
error bars represent one standard deviation (n=3). 
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Table A.43 – NorCMC Degradation Data from 4 wt% Total, 30% CNF Hydrogels: The mass-
based percentage of NorCMC lost from the 4 wt% total, 30% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 0 0 0 0 
1 60±1 40±1 30±6 30±10 
7 80±5 60±1 50±9 40±10 
14 80±3 70±0 50±8 60±10 
21 90±2 80±3 60±10 60±10 
28 90±2 80±4 60±10 70±5 
 
 
Figure A.44 – NorCMC Degradation Data from 4 wt% Total, 30% CNF Hydrogels: The mass-
based percentage of NorCMC lost over time from the 4 wt% total, 30% CNF hydrogels. The 
error bars represent one standard deviation (n=3). 
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Table A.44 – NorCMC Degradation Data from 4 wt% Total, 50% CNF Hydrogels: The mass-
based percentage of NorCMC lost from the 4 wt% total, 50% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 0 0 0 0 
1 60±8 40±10 30±3 20±8 
7 80±10 50±8 40±2 20±5 
14 90±10 60±4 40±2 30±4 
21 90±10 60±7 40±4 30±5 
28 90±10 60±8 40±5 40±6 
 
 
Figure A.45 – NorCMC Degradation Data from 4 wt% Total, 50% CNF Hydrogels: The mass-
based percentage of NorCMC lost over time from the 4 wt% total, 50% CNF hydrogels. The 
error bars represent one standard deviation (n=3). 
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A.4.2 CNF Degradation Assay Data 
 
Table A.45 – CNF Degradation Data from 2 wt% Total, 10% CNF Hydrogels: The mass-based 
percentage of CNF lost from the 2 wt% total, 10% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 0 0 0 0 
1 40±9 10±1 8±3 4±3 
7 90±10 20±0 8±3 6±2 
14 100 20±0 10±5 6±2 
21 100 20±1 10±5 6±2 
28 100 20±1 10±5 6±2 
 
 
Figure A.46 – CNF Degradation Data from 2 wt% Total, 10% CNF Hydrogels: The mass-based 
percentage of CNF lost over time from the 2 wt% total, 10% CNF hydrogels. The error bars 
represent one standard deviation (n=3). 
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Table A.46 – CNF Degradation Data from 2 wt% Total, 30% CNF Hydrogels: The mass-based 
percentage of CNF lost from the 2 wt% total, 30% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 0 0 0 0 
1 100 20±6 20±10 0±0 
7 100 40±10 20±9 0±0 
14 100 50±7 20±9 0±0 
21 100 50±7 20±9 0±0 
28 100 50±7 40±30 2±2 
 
 
Figure A.47 – CNF Degradation Data from 2 wt% Total, 30% CNF Hydorgels: The mass-based 
percentage of CNF lost over time from the 2 wt% total, 30% CNF hydrogels. The error bars 
represent one standard deviation (n=3). 
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Table A.47 – CNF Degradation Data from 2 wt% Total, 50% CNF Hydrogels: The mass-based 
percentage of CNF lost from the 2 wt% total, 50% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 
N/A 
0 0 0 
1 30±2 20±2 10±1 
7 50±8 30±2 20±6 
14 60±8 40±6 30±5 
21 70±4 50±6 40±7 
28 80±7 50±5 40±6 
 
 
Figure A.48 – CNF Degradation Data from 2 wt% Total, 50% CNF Hydrogels: The mass-based 
percentage of CNF lost over time from the 2 wt% total, 50% CNF hydrogels. The error bars 
represent one standard deviation (n≥2). 
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Table A.48 – CNF Degradation Data from 4 wt% Total, 10% CNF Hydrogels: The mass-based 
percentage of CNF lost from the 4 wt% total, 10% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 0 0 0 0 
1 30±10 10±4 6±1 0±1 
7 40±10 10±4 20±10 0±1 
14 40±10 10±4 20±10 0±1 
21 40±10 10±4 20±10 0±1 
28 50±3 10±4 20±10 0±1 
 
 
Figure A.49 – CNF Degradation Data from 4 wt% Total, 10% CNF Hydrogels: The mass-based 
percentage of CNF lost over time from the 4 wt% total, 10% CNF hydrogels. The error bars 
represent one standard deviation (n=3). 
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Table A.49 – CNF Degradation Data from 4 wt% Total, 30% CNF Hydrogels: The mass-based 
percentage of CNF lost from the 4 wt% total, 30% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 0 0 0 0 
1 40±9 10±5 1±1 2±1 
7 50±5 10±5 1±1 2±1 
14 50±5 10±5 1±1 2±1 
21 50±2 10±5 1±1 2±1 
28 50±2 10±5 1±1 2±1 
 
 
Figure A.50 – CNF Degradation Data from 4 wt% Total, 30% CNF Hydrogels: The mass-based 
percentage of CNF lost over time from the 4 wt% total, 30% CNF hydrogels. The error bars 
represent one standard deviation (n=3). 
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Table A.50 – CNF Degradation Data from 4 wt% Total, 50% CNF Hydrogels: The mass-based 
percentage of CNF lost from the 4 wt% total, 50% CNF hydrogels over time. 
Time (days) T:Nb = 0.25 T:Nb = 0.5 T:Nb = 0.75 T:Nb = 1 
0 0 0 0 0 
1 50±8 20±3 10±2 1±1 
7 60±9 30±4 10±1 1±2 
14 70±10 30±4 10±1 1±2 
21 70±10 30±6 10±1 1±2 
28 70±20 30±6 10±1 1±2 
 
 
Figure A.51 – CNF Degradation Data from 4 wt% Total, 50% CNF Hydogels: The mass-based 
percentage of CNF lost over time from the 4 wt% total, 50% CNF hydrogels. The error bars 
represent one standard deviation (n=3). 
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A.4.3 Calculated NorCMC and CNF Degradation Assay Data 
 
Table A.51 – Calculated Polymeric Losses from 2 wt% Total, 10% CNF Hydrogels: The 
calculated mass-based percentages of NorCMC and CNF lost from the 2 wt% total, 10% CNF 
hydrogels after either 24 hours (burst release) or 28 days (total). 
 Burst Release (%) Total Loss (%) 
T:Nb NorCMC CNF NorCMC CNF 
0.25 30±2 4±1 90 10 
0.5 40±7 3±3 80±9 4±3 
0.75 20±4 1±0 60±10 1±1 
1 20±2 0±0 70±7 1±0 
 
 
Figure A.52 – Calculated Burst Releases from 2 wt% Total, 10% CNF Hydrogels: The calculated 
mass-based percentages of  NorCMC and CNF lost from the 2 wt% total, 10% CNF hydrogels 
after 24 hours. The error bars represent one standard deviation (n=3). 
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Figure A.53 – Calculated Total Losses from 2 wt% Total, 10% CNF Hydrogels: The calculated 
mass-based percentages of  NorCMC and CNF lost from the 2 wt% total, 10% CNF hydrogels 
after 28 days. The error bars represent one standard deviation (n=3). 
 
Table A.52 – Calculated Polymeric Losses from 2 wt% Total, 30% CNF Hydrogels: The 
calculated mass-based percentages of NorCMC and CNF lost from the 2 wt% total, 10% CNF 
hydrogels after either 24 hours (burst release) or 28 days (total). 
 Burst Release (%) Total Loss (%) 
T:Nb NorCMC CNF NorCMC CNF 
0.25 70 30 70 30 
0.5 30±2 8±2 60±10 20±2 
0.75 10±2 5±3 50±10 10±9 
1 20±4 0±0 50±20 1±1 
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Figure A.54 – Calculated Burst Releases from 2 wt% Total, 30% CNF Hydrogels: The calculated 
mass-based percentages of  NorCMC and CNF lost from the 2 wt% total, 30% CNF hydrogels 
after 24 hours. The error bars represent one standard deviation (n=3). 
 
 
Figure A.55 – Calculated Total Losses from 2 wt% Total, 30% CNF Hydrogels: The calculated 
mass-based percentages of NorCMC and CNF lost from the 2 wt% total, 30% CNF hydrogels 
after 28 days. The error bars represent one standard deviation (n=3). 
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Table A.53 – Calculated Polymeric Losses from 2 wt% Total, 50% CNF Hydrogels: The 
calculated mass-based percentages of NorCMC and CNF lost from the 2 wt% total, 50% CNF 
hydrogels after either 24 hours (burst release) or 28 days (total). 
 Burst Release (%) Total Loss (%) 
T:Nb NorCMC CNF NorCMC CNF 
0.25 N/A N/A N/A N/A 
0.5 30±4 20±1 20±2 50 
0.75 30±4 20±1 30±4 50 
1 10±3 10±3 10±1 50 
 
 
Figure A.56 – Calculated Burst Releases from 2 wt% Total, 50% CNF Hydrogels: The calculated 
mass-based percentages of NorCMC and CNF lost from the 2 wt% total, 50% CNF hydrogels 
after 24 hours. The error bars represent one standard deviation (n≥2). 
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Figure A.57 – Calculated Total Losses from 2 wt% Total, 50% CNF Hydrogels: The calculated 
mass-based percentages of NorCMC and CNF lost from the 2 wt% total, 50% CNF hydrogels 
after 28 days. The error bars represent one standard deviation (n≥2). 
 
Table A.54 – Calculated Polymeric Losses from 4 wt% Total, 10% CNF Hydrogels: The 
calculated mass-based percentages of NorCMC and CNF lost from the 4 wt% total, 10% CNF 
hydrogels after either 24 hours (burst release) or 28 days (total). 
 Burst Release (%) Total Loss (%) 
T:Nb NorCMC CNF NorCMC CNF 
0.25 50±6 3±1 80±6 5±0 
0.5 30±2 1±0 50±3 1±0 
0.75 30±6 1±0 30±10 2±1 
1 20±5 0±0 30±10 0±0 
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Figure A.58 – Calculated Burst Releases from 4 wt% Total, 10% CNF Hydrogels: The calculated 
mass-based percentages of NorCMC and CNF lost from the 4 wt% total, 10% CNF hydrogels 
after 24 hours. The error bars represent one standard deviation (n=3). 
 
 
Figure A.59 – Calculated Total Losses from 4 wt% Total, 10% CNF Hydrogels: The calculated 
mass-based percentages of  NorCMC and CNF lost from the 4 wt% total, 10% CNF hydrogels 
after 28 days. The error bars represent one standard deviation (n=3). 
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Table A.55 – Calculated Polymeric Losses from 4 wt% Total, 30% CNF Hydrogels: The 
calculated mass-based percentages of NorCMC and CNF lost from the 4 wt% total, 30% CNF 
hydrogels after either 24 hours (burst release) or 28 days (total). 
 Burst Release (%) Total Loss (%) 
T:Nb NorCMC CNF NorCMC CNF 
0.25 40±1 10±3 60±2 20±1 
0.5 30±1 3±1 50±3 4±2 
0.75 20±4 0±0 40±7 0±0 
1 20±6 1±0 50±3 1±0 
 
 
Figure A.60 – Calculated Burst Releases from 4 wt% Total, 30% CNF Hydrogels: The calculated 
mass-based percentages of NorCMC and CNF lost from the 4 wt% total, 30% CNF hydrogels 
after 24 hours. The error bars represent one standard deviation (n=3). 
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Figure A.61 – Calculated Total Losses from 4 wt% Total, 30% CNF Hydrogels: The calculated 
mass-based percentages of NorCMC and CNF lost from the 4 wt% total, 30% CNF hydrogels 
after 28 days. The error bars represent one standard deviation (n=3). 
 
Table A.56 – Calculated Polymeric Losses from 4 wt% Total, 50% CNF Hydrogels: The 
calculated mass-based percentages of NorCMC and CNF lost from the 4 wt% total, 50% CNF 
hydrogels after either 24 hours (burst release) or 28 days (total). 
 Burst Release (%) Total Loss (%) 
T:Nb NorCMC CNF NorCMC CNF 
0.25 30±4 20±4 50±5 40±9 
0.5 20±5 10±1 30±5 20±3 
0.75 10±1 6±1 20±2 7±1 
1 9±4 1±1 20±3 2±2 
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Figure A.62 – Calculated Burst Releases from 4 wt% Total, 50% CNF Hydrogels: The calculated 
mass-based percentages of NorCMC and CNF lost from the 4 wt% total, 50% CNF hydrogels 
after 24 hours. The error bars represent one standard deviation (n=3). 
 
 
 
Figure A.63 – Calculated Total Losses from 4 wt% Total, 50% CNF Hydrogels: The calculated 
mass-based percentages of NorCMC and CNF lost from the 4 wt% total, 50% CNF hydrogels 
after 28 days. The error bars represent one standard deviation (n=3). 
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A.4.4 Development of Degradation Assay for CNF Quantification 
 
Originally, the same degradation assay used to quantify NorCMC was used to quantify 
CNF. Upon further investigation of this assay and its results, it was deemed inaccurate and 
unreliable for CNF quantification. As a result, a new assay for quantification was developed 
specifically for CNF. The first challenge of determining the procedure for CNF quantification was 
examining the products of the degradation reaction. Previously, in the NorCMC quantification 
assays, the maximum absorbance of the colorimetric product occurred at a wavelength of 545 nm 
(Figure A.64). Initially, after the same two-hour time period that the collected CNF hydrogel 
degradation solutions were allowed to react with the DHN-H2SO4 solution, the products were 
examined as usual using UV-Vis spectroscopy. The spectrum showed a maximum, but instead of 
being located at a wavelength of 545 nm, it had shifted down to 481 nm (Figure A.65). This 
indicated that the CNF degradation reaction product was different from the NorCMC product, 
while still maintaining similarities such as the ability to be detected and provide maximum 
absorbances. 
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Figure A.64 – UV-Vis Spectrum of NorCMC Degradation Products: The UV-Vis spectrum 
showing the maximum absorbance located at a wavelength of 545 nm when quantifying the 
colorimetric product of the NorCMC degradation reaction. 
 
 
Figure A.65 – UV-Vis Spectrum of CNF Degradation Products: The UV-Vis spectrum showing 
the maximum absorbance located at a wavelength of 481 nm when quantifying the colorimetric 
product of the CNF degradation reaction. 
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enough, a portion of the CNF would remain in the solution, and therefore not contribute to the 
absorbance at 481 nm. A lack of CNF representation within the absorbance values would lead to 
inaccurate calculations of the masses of CNF within the solutions. Inaccurate masses of CNF 
within the solutions would throw off the calculation of total CNF originally in the system as well 
as the calculation of the percentage of CNF lost at various times. Initially, the collected solutions 
were allowed to react for two hours before being analyzed via UV-Vis spectroscopy. To determine 
whether the reaction was finished after 2 hours, the reaction ran for 24 hours under the same 
experimental methods. The results of running the reaction for 24 hours showed that the maximum 
absorbance did in fact increase, indicating that a 2-hour runtime for the reaction was insufficient 
for the entire reaction. With this information, the same reaction was performed again for 48 hours 
to determine if the reaction continued after 24 hours. The results of the 48-hour reaction were 
compared to the 2- and 24-hour reactions and confirmed that the reaction had run to completion 
after 24 hours. 
The requirement for a longer runtime for the CNF degradation reaction with the DHN-
H2SO4 solution is similar to the enzymatic cellulose degradation of hydrogels made with CNF. As 
described previously, there were occasions when the hydrogels made with CNF required more 
time to degrade fully. Following that logic, the CNF degradation assay, which was essentially a 
modified NorCMC degradation assay, required more time to completely breakdown the CNF and 
create the colorimetric product that was readily detected via UV-Vis spectroscopy and used to 
quantify the amount of CNF within the solutions. 
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A.5 Enzymatic Cellulose Degradation of Hydrogels 
 
In order to use 1H NMR spectroscopy to investigate the success of the chemical 
crosslinking thiol-ene reactions, hydrogels were degraded using a cellulase enzyme to make them 
soluble. Hydrogels were either swollen in PBS as previously described or made and then 
immediately introduced to the cellulase enzyme. Because cellulase from Trichoderma reesei 
works most effectively at pH = 5 and 50 °C, the hydrogels were placed in a 2 mL microcentrifuge 
tube and 2 mL of sodium acetate buffer (pH = 5) was added. Following this, 10 µL of cellulase 
from Trichoderma reesei was added for every hydrogel. Anywhere from 3 to 6 hydrogels were 
added to each microcentrifuge tube. The microcentrifuge tubes were then placed into a sand bath, 
kept at 50 °C, where the hydrogels initially degraded for 24 hours. The majority of the hydrogel 
formulations had completely degraded after 24 hours, and the solutions did not contain any solid 
particulates. Any hydrogels that failed to degrade completely were left for another 24 hours. 
After being completely degraded, the hydrogel solutions were freeze dried using the 
lyophilization methods previously described. Once the solutions were freeze dried, 650 µL of D2O 
was added to the microcentrifuge tube and the mixture was vortexed until homogenous. These 
solutions were then added to glass NMR tubes and NMR spectroscopy was performed. Following 
previous experiments, the samples were given a delay time of 2 seconds and spectra were obtained 
using 64 scans. Mestrenova software was used to analyze the retrieved spectra, with the D2O 
solvent peak found at 4.79 ppm used as the reference peak. 
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A.6 Hydrogels in NMR Tubes 
 
A.6.1 Synthesis of Hydrogels in NMR Tubes 
 
In order to analyze the sol fraction of the hydrogels created via 1H NMR spectroscopy, 
hydrogels were synthesized using glass NMR tubes as molds. Following similar hydrogel synthesis 
methods performed prior, the appropriate mass of NorCMC was added to D2O and vortexed until 
homogenous. Both DTT and I2959 stock solutions were made using the same methods as before, 
with the exception of using D2O rather than PBS as the solvent. The UV lamp was calibrated to 
have a power of approximately 10 mW/cm2 when accommodating an upright NMR tube. The 
components of the hydrogel solutions were then added like before and transferred to NMR tubes 
via long stem Pasteur pipettes. The hydrogel solutions were then irradiated for 60 seconds before 
1H NMR analysis was performed. 
 
A.6.2 1HNMR Spectra of Hydrogels Synthesized in NMR Tubes 
 
The 1H NMR spectra of the hydrogels synthesized in NMR tubes revealed the sol fractions 
of the various hydrogel formulations. Because the sol fraction is the part material that is not 
incorporated into the network, in this case the sol fraction would be liquid-like, and therefore able 
to be detected by NMR. The materials incorporated into the hydrogels would not be seen in NMR 
spectra, as they exhibit more solid-like characteristics. While it was clear that the solutions had 
gelled, due to the fact that the NMR tubes could be placed in any orientation and the materials 
would not move, there was a clear residue that would move slightly along the sides of the NMR 
tubes when they were moved. This residue was the sol fraction, which revealed everything that 
was left out of the hydrogel networks following the reaction. 
In all formulations, clear and distinct alkene peaks could be seen, and thus imply that none 
of these reactions ran to completion. A complete reaction would result in all the alkenes undergoing 
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the thiol-ene reaction, and therefore removing the alkene peaks seen in the original NorCMC 
spectra. Instead, the NMR spectra show clear traces of alkenes present in the sol fractions from all 
the formulations. 
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A.7 Live/Dead Assay for Cell Viability Data 
 
 
Figure A.66 – Live/Dead Assay of a NorCMC Hydrogel: A fluorescence microscopy image (5x 
magnification) showing the center of a NorCMC hydrogel. 
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Figure A.67 – Live/Dead Assay of a NorCMC Hydrogel: A fluorescence microscopy image (5x 
magnification) showing the edge of a NorCMC hydrogel. 
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Figure A.68 – Live/Dead Assay of a NorCMC Hydrogel: A fluorescence microscopy image (5x 
magnification) showing the edge of a NorCMC hydrogel. 
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Figure A.69 – Live/Dead Assay of a NorCMC Hydrogel: A fluorescence microscopy image (5x 
magnification) showing the edge of a NorCMC hydrogel. 
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Figure A.70 – Live/Dead Assay of a NorCMC Hydrogel: A fluorescence microscopy mosaic (5x 
magnification) of a NorCMC hydrogel. 
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Figure A.71 – Live/Dead Assay of a 4 wt%, 50% CNF Hydrogel: A fluorescence microscopy 
image (5x magnification) of a cross section of a hydrogel made using a 4 wt% total, 50% CNF, 
and T:Nb = 1. 
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Figure A.72 – Live/Dead Assay of a 4 wt%, 50% CNF Hydrogel: A fluorescence microscopy 
image (5x magnification) of a cross section of a hydrogel made using a 4 wt% total, 50% CNF, 
and T:Nb = 1. 
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Figure A.73 – Live/Dead Assay Mosaic of a 4 wt%, 50% CNF Hydrogel: A fluorescence 
microscopy mosaic (5x magnification) of a cross section of a hydrogel made using a 4 wt% total, 
50% CNF, and T:Nb = 1. The hydrogel was moving, so the images do not line up. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
171 
B. Glycan Functionalized NorCMC Hydrogels 
 
Hydrogels can be functionalized using a variety of small molecules. NorCMC hydrogels 
were functionalized using a lactose amine glycan. The lactose amine contained a terminal thiol 
(Figure B.1), which reacted with the norbornene groups via thiol-ene reactions. 
 
Figure B.1 – Lactose Amine Chemical Structure: The chemical structure of lactose amine. 
 
B.1 Synthesis of Lactose Amine Functionalized NorCMC Hydrogels 
 
Because the lactose amine existed as a disulfide, prior to hydrogel formation and 
functionalization, a reduction was required. Stock solutions of lactose amine (0.1 M) and sodium 
borohydride (1 M) were made using PBS. The reduction ran under a constant nitrogen purge for 
30 minutes. During this time the appropriate amount of NorCMC was dissolved into PBS. This 
NorCMC solution was then used to quench the reduction. 
DTT was used as the crosslinker for these hydrogels, and 1 M stock solutions of DTT were 
made fresh every day. Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) was used as the 
photoinitiator in these systems, and, like I2959, a 0.5 wt% stock solution was created on an as 
needed basis. Following quenching, the appropriate volumes of DTT and LAP stock solutions 
were used added to the solution. The lactose amine hydrogels were made using a T:Nb = 0.75, and 
the lactose amine had a final concentration within the hydrogel solutions of 2 mM. The hydrogels 
were synthesized using the methods described in Chapter 2. 
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B.2 Quantifying Lactose Amine Loss from NorCMC Hydrogels Over Time 
 
Using the previously created 0.1 M lactose amine stock solution, standards of varying 
concentrations were prepared. The standards were created using serial dilutions beginning at 0.25 
mM and ending at 0.015625 mM. To examine them using a Spectramax i3x plate reader, the 
lactose amine hydrogels were removed from their wells and individually placed into wells within 
a 96-well plate. A well scan was used to measure the fluorescence of the lactose amine, with an 
excitation at 340 nm and an emission at 430 nm. The NorCMC losses from these hydrogels were 
quantified using the same procedures outlined in Chapter 2. 
 
B.3 Results of Lactose Amine Functionalized NorCMC Hydrogels 
 
The results from the plate reader revealed that the majority of the lactose amine was 
successfully attached to the NorCMC and remained within the hydrogels for three weeks (Table 
B.1). The burst release revealed that approximately 7% of the lactose amine did not successfully 
react with the norbornene groups. The NorCMC losses revealed that the hydrogels remained intact 
over the course of the three weeks, only losing approximately 20% of their contents (Figure B.2). 
The lactose amine losses may be attributed to the NorCMC losses, as any loss of NorCMC would 
correlate to the loss of any lactose amine attached. 
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Table B.1 – Lactose Amine Lost Over Time: The mass-based percentages of lactose amine lost 
over time. 
 Time (days) Lactose Amine Lost (%)  
 1 7±3  
 2 9±3  
 3 10±4  
 4 10±4  
 5 10±6  
 6 10±6  
 7 20±8  
 8 20±7  
 9 20±10  
 21 20±10  
 
 
Figure B.2 – NorCMC and Lactose Amine Losses Over Time: The mass-based percentages of 
NorCMC and lactose amine lost over time. The percentages are based on each component 
individually, and the error bars represent one standard deviation (n≥5). 
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